References
References 1-50
Ref. 1. American Association for Cancer Research. AACR Cancer Progress Report 2023. Accessed: Feb 29, 2024. Available from:
https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2023/10/AACR_CPR_2023_102423.pdf
Ref. 2. Islami F, et al. (2023) CA Cancer J Clin, 74: 136
Ref. 3. NCI Surveillance, Epidemiology, and End Results Program. NCI SEER*Explorer. Accessed: March 17, 2024. Available from:
https://seer.cancer.gov/statistics-network/explorer/application.html
Ref. 4. Centers for Disease Control and Prevention. Cancer Statistics At a Glance. Accessed: March 17, 2024. Available from:
https://gis.cdc.gov/Cancer/USCS/#/AtAGlance
Ref. 5. Espey DK, et al. (2014) Am J Public Health, 104 Suppl 3: S286.
Ref. 6. Espey DK, et al. (2008) Cancer, 113: 1120.
Ref. 7. Satpathy Y, et al. (2023) JAMA Netw Open, 6: e2350237.
Ref. 8. Haverkamp D, et al. (2023) Int J Circumpolar Health, 82: 2184749.
Ref. 9. Centers for Disease Control and Prevention. Cancer Statistics At a Glance: American Indian and Alaska Native. Accessed: March 17, 2024. Available from:
https://gis.cdc.gov/Cancer/USCS/#/AIAN/
Ref. 10. Li DY, et al. (2022) J Natl Cancer Inst, 114: 1238.
Ref. 11. Llanos AAM, et al. (2022) Front Oncol, 12: 857548.
Ref. 12. Winkler SS, et al. (2024) Gynecol Oncol, 184: 31.
Ref. 13. Pacific Regional Central Cancer Registry. Cancer in the U.S. Affiliated Pacific Islands 2007-2020. Accessed: March 17, 2024. Available from:
https://pacificcancer.org/wp-content/uploads/sites/50/2023/04/PIJ-Cancer-Facts-Figures-2007-2020-Final-to-share_smallfile.pdf
Ref. 14. Kratzer TB, et al. (2023) CA Cancer J Clin, 73: 120.
Ref. 15. KFF. Health Coverage Among American Indian and Alaska Native and Native Hawaiian and Other Pacific Islander People. Accessed: March 17, 2024. Available from:
https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-coverage-among-american-indian-and-alaska-native-and-native-hawaiian-and-other-pacific-islander-people/
Ref. 16. Pew Research Center. Asian Americans are the fastest-growing racial or ethnic group in the U.S. Accessed: March 17, 2024. Available from:
https://www.pewresearch.org/short-reads/2021/04/09/asian-americans-are-the-fastest-growing-racial-or-ethnic-group-in-the-u-s/
Ref. 17. Giaquinto AN, et al. (2022) CA Cancer J Clin, 72: 524.
Ref. 18. Centers for Disease Control and Prevention. Underlying Cause of Death, 2018-2021, Single Race. Accessed: March 17, 2024. Available from:
https://wonder.cdc.gov/ucd-icd10-expanded.html
Ref. 19. Lee RJ, et al. (2021) Oncologist, 26: 453.
Ref. 20. Polk DB, et al. (2010) Nat Rev Cancer, 10: 403.
Ref. 21. Shing JZ, et al. (2023) JNCI Cancer Spectr, 7: pkad012.
Ref. 22. Kooragayala K, et al. (2024) Ann Surg Oncol, 31: 1298.
Ref. 23. Pinheiro PS, et al. (2022) Lung Cancer, 174: 50.
Ref. 24. DeRouen MC, et al. (2022) J Natl Cancer Inst, 114: 78.
Ref. 25. Daylan AEC, et al. (2023) Lung, 201: 521.
Ref. 26. University of California San Francisco. FANS Study. Accessed: March 17, 2024. Available from:
https://fansstudy.ucsf.edu/home
Ref. 27. Pew Research Center. Facts About the U.S. Black Population. Accessed: March 17, 2024. Available from: https://www.pewresearch.org/social-trends/fact-sheet/facts-about-the-us-black-population/
Ref. 28. Giaquinto AN, et al. (2022) CA Cancer J Clin, 72: 202.
Ref. 29. Stringer-Reasor EM, et al. (2021) Am Soc Clin Oncol Educ Book, 41: e29.
Ref. 30. Cranford HM, et al. (2023) Cancers (Basel), 15. 2165.
Ref. 31. Markides KS, et al. (1986) Public Health Rep, 101: 253.
Ref. 32. Fernandez J, et al. (2023) Journal of Economic Perspectives, 37: 145.
Ref. 33. Pompa IR, et al. (2023) JAMA Oncol, 9: 1090.
Ref. 34. Gupta S, et al. (2023) Lancet Haematol, 10: e129.
Ref. 35. Centers for Disease Control and Prevention. Declines in Cancer Death Rates Among Youth: United States, 2001-2021. Accessed: Mar 13, 2024. Available from:
https://www.cdc.gov/nchs/data/databriefs/db484.pdf
Ref. 36. Miller KD, et al. (2021) CA Cancer J Clin, 71: 466.
Ref. 37. Swami N, et al. (2023) Prostate Cancer Prostatic Dis, 26: 309.
Ref. 38. Siegel RL, et al. (2024) CA Cancer J Clin, 74: 12.
Ref. 39. Rosario-Santos A, et al. (2023) Gynecol Oncol Rep, 49: 101275.
Ref. 40. Fejerman L, et al. (2022) Cancer Epidemiol Biomarkers Prev, 31: 932. Available from:
https://aacrjournals.org/cebp/article/31/5/932/694726/Cancer-Epidemiology-in-Hispanic-Populations-What
Ref. 41. University of Hawai‘i Cancer Center. Hawai‘i Cancer at a Glance 2012-2016. Accessed: March 17, 2024. Available from:
https://www.uhcancercenter.org/pdf/htr/Hawaii%20Cancer%20at%20 a%20Glance%202012_2016.pdf
Ref. 42. Haque AT, et al. (2023) J Natl Cancer Inst, 115: 822.
Ref. 43. Decker HC, et al. (2023) JAMA Netw Open, 6: e2349143.
Ref. 44. Keegan THM, et al. (2024) J Clin Oncol, 42: 630.
Ref. 45. Kim HW, et al. (2020) Clin Transl Gastroenterol, 11: e00242.
Ref. 46. Fowler ME, et al. (2023) J Geriatr Oncol, 14: 101505.
Ref. 47. Oladeru OT, et al. (2022) PLoS One, 17: e0274703.
Ref. 48. Mohamed AA, et al. (2023) Cancer Med, 12: 20027.
Ref. 49. US Department of Agriculture. Economic Research Service. Rural-Urban Continuum Codes. Accessed: March 17, 2024. Available from:
https://www.ers.usda.gov/data-products/rural-urban-continuum-codes/
Ref. 50. National Center for Health Statistics. Percentage of any type of cancer for adults aged 18 and over, United States, 2019—2022. Accessed: March 17, 2024. Available from:
https://wwwn.cdc.gov/NHISDataQueryTool/SHS_adult/index.html
References 51-100
Ref. 51. Hernandez AE, et al. (2023) Am Surg, 90: 510.
Ref. 52. Sokale IO, et al. (2023) Cancer Med, 12: 18988.
Ref. 53. Tobin EC, et al. (2023) Am Surg, 89: 3163.
Ref. 54. US Department of Agriculture. Rural America at a Glance. 2023 Edition. Accessed: March 26, 2024. Available from:
https://www.ers.usda.gov/webdocs/publications/107838/eib-261.pdf?v=5345.9
Ref. 55. Pew Research Center. 5 key findings about LGBTQ+ Americans. Accessed: March 17, 2024. Available from:
https://www.pewresearch.org/short-reads/2023/06/23/5-key-findings-about-lgbtq-americans/
Ref. 56. National Academies of Sciences E, et al. Understanding the Well-Being of LGBTQI+ Populations. Patterson CJ, Sepúlveda M-J, White J, editors. Washington, DC: The National Academies Press; 2020. p. 436.
Ref. 57. Clavelle K, et al. (2015) Womens Health Issues, 25: 341.
Ref. 58. Williams AD, et al. (2020) LGBT Health, 7: 109.
Ref. 59. Jackson SS, et al. (2021) J Natl Cancer Inst, 113: 1221.
Ref. 60. de Blok CJM, et al. (2019) BMJ, 365: l1652.
Ref. 61. McFarlane T, et al. (2018) Clin Endocrinol (Oxf), 89: 700.
Ref. 62. Raths F, et al. (2023) Cell Genom, 3: 100272.
Ref. 63. Brown GR, et al. (2015) Breast Cancer Res Treat, 149: 191.
Ref. 64. Unger CA (2016) Transl Androl Urol, 5: 877.
Ref. 65. Yazdanpanah O, et al. (2023) Cancers (Basel), 15: 2654.
Ref. 66. Manfredi C, et al. (2023) Curr Oncol Rep, 25: 1431.
Ref. 67. Clifford GM, et al. (2021) Int J Cancer, 148: 38.
Ref. 68. Machalek DA, et al. (2012) Lancet Oncol, 13: 487.
Ref. 69. Eckhert E, et al. (2023) JAMA Oncol, 9: 473.
Ref. 70. All of Us Research Program Investigators, et al. (2019) N Engl J Med, 381: 668.
Ref. 71. Tran NK, et al. (2023) JAMA Netw Open, 6: e2324969.
Ref. 72. Leone AG, et al. (2023) JAMA Oncol, 9: 556.
Ref. 73. Fight Cancer. Survivor Views LGBTQ+ Cancer Patients & Survivors June 2023. Accessed: March 17, 2024. Available from:
https://www.fightcancer.org/sites/default/files/national_documents/lgbtq_patient_discrimination_0.pdf
Ref. 74. Office of the Assistant Secretary for Planning and Evaluation. Poverty Guidelines. Accessed: March 17, 2024. Available from:
https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines
Ref. 75. Census.gov. Persistent Poverty in Counties and Census Tracts. Accessed: March 17, 2024. Available from:
https://www.census.gov/content/dam/Census/library/publications/2023/acs/acs-51%20persistent%20poverty.pdf
Ref. 76. Papageorge MV et al, (2023) Ann Surg, 277: 995.
Ref. 77. Moss JL, et al. (2022) J Natl Cancer Inst, 114: 829.
Ref. 78. Hoppmann AL, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 380. Available from:
https://aacrjournals.org/cebp/article/32/3/380/718486/Persistent-Child-Poverty-and-Mortality-in-a-Cohort
Ref. 79. Hall JM, et al. (2022) Prev Med Rep, 29: 101922.
Ref. 80. Amboree TL, et al. (2024) Int J Cancer, 154: 1549.
Ref. 81. LaVeist TA, et al. (2023) JAMA, 329: 1682.
Ref. 82. Yabroff KR, et al. (2021) J Natl Cancer Inst, 113: 1670.
Ref. 83. Islami F, et al. (2022) Int J Cancer, 151: 2095.
Ref. 84. Kaur A, et al. (2023) Gynecol Oncol, 170: 266.
Ref. 85. Parsons SK, et al. (2023) J Clin Oncol, 41: 3260.
Ref. 86. Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Accessed: June 30, 2023. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK220358/
Ref. 87. Warnecke RB, et al. (2008) Am J Public Health, 98: 1608.
Ref. 88. Asare M, et al. (2017) Oncol Nurs Forum, 44: 20.
Ref. 89. American Association for Cancer Research. AACR Cancer Disparities Progress Report 2022. Accessed: June 30, 2023. Available from:
https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2022/06/AACR_CDPR_2022.pdf
Ref. 90. US Department of Agriculture. Dietary Guidelines for Americans 2020-2025. Accessed: March 17, 2024. Available from:
https://www.dietaryguidelines.gov/sites/default/files/2021-03/Dietary_Guidelines_for_Americans-2020-2025.pdf
Ref. 91. Puthanmadhom Narayanan S, et al. (2023) NPJ Breast Cancer, 9: 90.
Ref. 92. Karanth SD, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 516. Available from:
https://aacrjournals.org/cebp/article/32/4/516/724753/The-Intersectionality-between-Race-Ethnicity-and
Ref. 93. Goel N, et al. (2023) JAMA Netw Open, 6: e238908.
Ref. 94. Ramadan S, et al. (2023) Oral Oncol, 147: 106607.
Ref. 95. Liu Y, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 642. Available from:
https://aacrjournals.org/cebp/article/32/5/642/726084/Neighborhood-Socioeconomic-Status-and-Racial-and
Ref. 96. Kind AJH, et al. (2018) New England Journal of Medicine, 378: 2456.
Ref. 97. Lane HM, et al. (2022) Environ Sci Technol Lett, 9: 345.
Ref. 98. Kraus NT, et al. (2023) Public Health Nurs. 1–10.
Ref. 99. Lee EK, et al. (2022) Soc Sci Med, 294: 114696.
Ref. 100. Egede LE, et al. (2023) J Gen Intern Med, 38: 1534.
References 101-150
Ref. 101. Loehrer AP, et al. (2023) Ann Surg, 277(2): 329.
Ref. 102. Zhang L, et al. (2023) JAMA Oncol, 9: 122.
Ref. 103. Bikomeye JC, et al. (2023) J Natl Cancer Inst, 115: 652.
Ref. 104. Hernandez AE, et al. (2024) Ann Surg Oncol, 31: 988.
Ref. 105. Purrington KS, et al. (2023) Cancer Med, 12: 14623.
Ref. 106. KFF. Key Data on Health and Health Care by Race and Ethnicity. Accessed: March 17, 2024. Available from:
https://www.kff.org/racial-equity-and-health-policy/report/key-data-on-health-and-health-care-by-race-and-ethnicity/
Ref. 107. Agency of Healthcare Research and Quality. Defining Health Systems. Accessed: March 17, 2024. Available from:
https://www.ahrq.gov/chsp/defining-health-systems/index.html
Ref. 108. McLaughlin CG, et al. (2002) Health Serv Res, 37: 1441.
Ref. 109. Zhao J, et al. (2022) CA Cancer J Clin, 72: 542.
Ref. 110. Himmelstein G, et al. (2024) JAMA Oncol, 10: 134.
Ref. 111. Leader AE, et al. (2022) Cancer Epidemiol Biomarkers Prev, 31: 955. Available from:
https://aacrjournals.org/cebp/article/31/5/955/694731/Assessing-the-Coverage-of-US-Cancer-Center-Primary
Ref. 112. Agaronnik N, et al. (2022) J Disabil Policy Stud, 33: 46.
Ref. 113. Holt HK, et al. (2023) JAMA Netw Open, 6: e232985.
Ref. 114. KFF. Survey on Racism, Discrimination and Health: Experiences and Impacts Across Racial and Ethnic Groups. Accessed: March 17, 2024. Available from:
https://www.kff.org/report-section/survey-on-racism-discrimination-and-health-findings/
Ref. 115. Darmon S, et al. (2023) Health Equity, 7: 178.
Ref. 116. Clark KD, et al. (2023) Int J Equity Health, 22: 162.
Ref. 117. Rodriquez EJ, et al. (2017) J Aging Health, 29: 805.
Ref. 118. Pratt-Chapman ML, et al. (2021) Syst Rev, 10: 183.
Ref. 119. Fuemmeler BF, et al. (2023) Mol Psychiatry, 28: 1494.
Ref. 120. Mohan A, et al. (2022) Eur J Cancer Prev, 31: 585.
Ref. 121. Gilham K, et al. (2023) PLoS One, 18: e0281588.
Ref. 122. Collin LJ, et al. (2022) Cancer, 128: 1312.
Ref. 123. Kano M, et al. (2022) Front Oncol, 12: 833195.
Ref. 124. Hu S, et al. (2023) J Natl Cancer Inst.
Ref. 125. Dent KR, et al. (2023) Cancer Med, 12: 3520.
Ref. 126. Morales S, et al. (2022) J Cancer Surviv, 16: 624.
Ref. 127. Madigan A, et al. (2023) J Affect Disord, 326: 36.
Ref. 128. Ridley M, et al. (2020) Science, 370: eaay0214.
Ref. 129. George G, et al. (2023) Current Treatment Options in Psychiatry, 10: 181.
Ref. 130. Malik MH, et al. (2023) Am J Mens Health, 17: 15579883231176646.
Ref. 131. American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2023-2024. Accessed: March 17, 2024. Available from:
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-prevention-and-early-detection-facts-and-figures/2024-cped-files/cped-2024-cff.pdf
Ref. 132. Cotangco KR, et al. (2023) Prev Chronic Dis, 20: E21.
Ref. 133. India-Aldana S, et al. (2023) Environ Health Perspect, 131: 107001.
Ref. 134. Virolainen SJ, et al. (2023) Genes Immun, 24: 1.
Ref. 135. Carbone M, et al. (2020) Nat Rev Cancer, 20: 533.
Ref. 136. Carrot-Zhang J, et al. (2020) Cancer Cell, 37: 639.
Ref. 137. Arora K, et al. (2022) Cancer Discov, 12: 2552. Available from:
https://aacrjournals.org/cancerdiscovery/article/12/11/2552/709989/Genetic-Ancestry-Correlates-with-Somatic
Ref. 138. Liu YL, et al. (2024) Cancer, 130: 576.
Ref. 139. James BA, et al. (2023) Front Genet, 14: 1141058.
Ref. 140. Chevallier M, et al. (2021) World J Clin Oncol, 12: 217.
Ref. 141. Landry LG, et al. (2018) Health Aff (Millwood), 37: 780.
Ref. 142. Belleau P, et al. (2023) Cancer Res, 83: 49. Available from:
https://aacrjournals.org/cancerres/article/83/1/49/711844/Genetic-Ancestry-Inference-from-Cancer-Derived
Ref. 143. All of Us Research Program Genomics Investigators. (2024) Nature, 627: 340.
Ref. 144. US Department of Health and Human Services. Office of Disease Prevention and Health Promotion. Health People 2023. Accessed: March 17, 2024. Available from:
https://health.gov/healthypeople/about
Ref. 145. Zhao J, et al. (2020) CA Cancer J Clin, 70: 165.
Ref. 146. Moss HA, et al. (2020) J Natl Cancer Inst, 112: 779.
Ref. 147. Graboyes EM, et al. (2022) J Natl Cancer Inst, 114: 1593.
Ref. 148. Jiang C, et al. (2023) Journal of Clinical Oncology, 41: 6534.
Ref. 149. Centers for Medicare & Medicaid Services. Non-Emergency Medical Transportation. Accessed: March 17, 2024. Available from:
https://www.cms.gov/medicare/medicaid-coordination/states/non-emergency-medical-transportation
Ref. 150. US Department of Veterans Affairs. Veterans Transportation Program (VTP) -Health Benefits. Accessed: March 17, 2024. Available from:
https://www.va.gov/healthbenefits/vtp/
References 151-200
Ref. 151. Damico N, et al. (2020) Int J of Radiat Oncol Biol Phys, 108: e388.
Ref. 152. Centers for Disease Control and Prevention. About the National Breast and Cervical Cancer Early Detection Program. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/cancer/nbccedp/about.htm
Ref. 153. Raber M, et al. (2022) J Natl Cancer Inst, 114: 1577.
Ref. 154. Gany FM, et al. (2020) J Health Care Poor Underserved, 31: 595.
Ref. 155. Gany F, et al. (2022) Journal of Clinical Oncology, 40: 3603.
Ref. 156. Human Services Research Institute. Evaluation of the Louisiana Permanent Supportive Housing Initiative. Accessed: March 17, 2024. Available from:
https://www.hsri.org//project/evaluation-of-the-louisiana-permanent-supportive-housing-initiative
Ref. 157. US Department of Health and Human Services. Office of Health Policy. Addressing Social Determinants of Health: Examples of Successful Evidence-Based Strategies and Current Federal Efforts. Accessed: March 17, 2024. Available from:
https://aspe.hhs.gov/sites/default/files/documents/e2b650cd64cf84aae8ff0fae7474af82/SDOH-Evidence-Review.pdf
Ref. 158. The White House. The U.S. Playbook to Address Social Determinants of Health. Accessed: March 17, 2024. Available from:
https://www.whitehouse.gov/wp-content/uploads/2023/11/SDOH-Playbook-3.pdf
Ref. 159. National Institutes of Health. NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men. Accessed: March 2017, 2024. Available from:
https://www.nih.gov/news-events/news-releases/nih-prostate-cancer-foundation-launch-large-study-aggressive-prostate-cancer-african-american-men
Ref. 160. University of Hawai‘i Cancer Center. The Multiethnic Cohort Study. Accessed: March 26, 2024. Available from:
https://www.uhcancercenter.org/mec
Ref. 161. Signorello LB, et al. (2010) J Health Care Poor Underserved, 21: 26.
Ref. 162. Rosenberg L, et al. (1995) J Am Med Womens Assoc, 50: 56.
Ref. 163. National Institutes of Health. All of Us Research Program. Accessed: March 17, 2024. Available from:
https://allofus.nih.gov/
Ref. 164. National Institutes of Health. NIH All of Us. Data Snapshots. Accessed: March 17, 2024. Available from:
https://www.researchallofus.org/data-tools/data-snapshots/
Ref. 165. Sanchez JI, et al. (2022) J Natl Cancer Inst, 114: 1628.
Ref. 166. The NCI Community Oncology Research Program (NCORP). Accessed: March 17, 2024. Available from:
https://ncorp.cancer.gov/
Ref. 167. The Cancer Letter. Participation by minority racial, ethnic groups in NCI-funded trials nearly doubles in 20 years. Accessed: March 17, 2024. Available from:
https://cancerletter.com/the-cancer-letter/20200626_1/
Ref. 168. Centers for Disease Control and Prevention. Racial and Ethnic Approaches to Community Health. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/nccdphp/dnpao/state-local-programs/reach/
Ref. 169. American Indian Cancer Foundation. American Indian Cancer Foundation Receives Funding to Improve Health and Prevent Chronic Disease in Native Communities. Accessed: March 17, 2024. Available from:
https://americanindiancancer.org/wp-content/uploads/2024/02/2024-News-Release-for-REACH-Recipients-Final.pdf
Ref. 170. Arring N, et al. (2023) J Natl Compr Canc Netw, 21: 481.
Ref. 171. Harandi TF, et al. (2017) Electron Physician, 9: 5212.
Ref. 172. Hoffman A, et al. The Many Faces of Social Connectedness and Their Impact on Well-being. In: Spini D, Widmer E, editors. Withstanding Vulnerability throughout Adult Life: Dynamics of Stressors, Resources, and Reserves. Singapore: Springer Nature Singapore; 2023. p 169.
Ref. 173. Kale S, et al. (2023) Cureus, 15: e43445.
Ref. 174. Wangen M, et al. (2023) Cancer Causes Control, 34: 45.
Ref. 175. Community Preventive Services Task Force. 2021 Annual Report to Congress. Accessed: March 17, 2024. Available from:
https://www.thecommunityguide.org/pages/2021-annual-report-congress.html
Ref. 176. Hiatt RA, et al. (2022) Cancer Prev Res (Phila), 15: 349. Available from: https://aacrjournals.org/cancerpreventionresearch/article/15/6/349/698962/Catchment-Areas-Community-Outreach-and-Engagement
Ref. 177. Hensel B, et al. (2023) J Cancer Educ, 38: 1429.
Ref. 178. Carnahan LR, et al. (2023) Prev Chronic Dis, 20: E69.
Ref. 179. Rana T, et al. (2023) Cancer Nurs, 10: 100287.
Ref. 180. Nouvini R, et al. (2022) Cancer, 128: 3860.
Ref. 181. Chan RJ, et al. (2023) CA Cancer J Clin, 73: 565.
Ref. 182. Hanahan D (2022) Cancer Discov, 12: 31. Available from:
https://aacrjournals.org/cancerdiscovery/article/12/1/31/675608/Hallmarks-of-Cancer-New-DimensionsHallmarks-of
Ref. 183. Gong J, et al. (2023) Nat Rev Urol, DOI: 10.1038/s41585-023-00828-w.
Ref. 184. Halmai NB, et al. (2022) Trends Cancer, 8: 291.
Ref. 185. Raghavan S (2022) Dis Model Mech, 15.
Ref. 186. Leon C, et al. (2023) Front Oncol, 13: 1187585.
Ref. 187. Stefanoudakis D, et al. (2023) Cancers (Basel), 15.
Ref. 188. Science Magazine. CRISPR’s ‘ancestry problem’ misses cancer targets in those of African descent. Accessed: March, 2024. Available from:
https://www.science.org/content/article/crispr-s-ancestry-problem-misses-cancer-targets-those-african-descent
Ref. 189. American Association for Cancer Research. AACR Cancer Progress Report 2021. Accessed: June 30, 2023. Available from:
https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2021/10/AACR_CPR_2021.pdf
Ref. 190. Timmermann A, et al. (2016) Nature, 538: 92.
Ref. 191. National Academies of Sciences, Engineering, and Medicine. 2023. Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field. Washington, DC: The National Academies Press. Available from:
https://doi.org/10.17226/26902
Ref. 192. Wang T, et al. (2022) Nature, 604: 437.
Ref. 193. Jaratlerdsiri W, et al. (2022) Nature, 609: 552.
Ref. 194. George SHL, et al. (2021) JAMA Netw Open, 4: e210307.
Ref. 195. Sia TY, et al. (2023) JCO Precis Oncol, 7: e2300137.
Ref. 196. de Smith AJ, et al. (2024) Cell Genom: 4: 100526.
Ref. 197. Mishra A, et al. (2024) Journal of Clinical Oncology, 42: 253.
Ref. 198. Wickland DP, et al. (2022) J Natl Cancer Inst, 114: 1192.
Ref. 199. Casolino R, et al. (2024) CA Cancer J Clin, 1–22.
Ref. 200. Jiagge E, et al. (2023) Cancer Cell, 41: 1963.
References 201-250
Ref. 201. Shi J, et al. (2023) Nat Commun, 14: 3043.
Ref. 202. Byun J, et al. (2022) Nat Genet, 54: 1167.
Ref. 203. Wang A, et al. (2023) Nat Genet, 55: 2065.
Ref. 204. Soh PXY, et al. (2023) Nat Commun, 14: 8037.
Ref. 205. Gong T, et al. (2022) Genome Med, 14: 100.
Ref. 206. Hein DM, et al. (2022) J Natl Cancer Inst, 114: 775.
Ref. 207. Holowatyj AN, et al. (2023) Cancer Discov, 13: 570. Available from:
https://aacrjournals.org/cancerdiscovery/article/13/3/570/716777/Racial-Ethnic-and-Sex-Differences-in-Somatic
Ref. 208. Perez-Mayoral J, et al. (2023) Genes (Basel), 14.
Ref. 209. Carrot-Zhang J, et al. (2021) Cancer Discov, 11: 591. Available from:
https://aacrjournals.org/cancerdiscovery/article/11/3/591/3322/Genetic-Ancestry-Contributes-to-Somatic-Mutations
Ref. 210. Shultz C, et al. (2023) Cancer Rep (Hoboken), 6: e1746.
Ref. 211. Bradley RK, et al. (2023) Nat Rev Cancer, 23: 135.
Ref. 212. Freedman JA, et al. (2021) Annu Rev Med, 72: 229.
Ref. 213. Asare A, et al. (2022) Cancer Res Commun, 2: 99.
Ref. 214. Jia G, et al. (2022) Am J Hum Genet, 109: 2185.
Ref. 215. Wang BD, et al. (2017) Nat Commun, 8: 15921.
Ref. 216. Kulkarni A, et al. (2022) Cells, 11: 2448.
Ref. 217. Ottman R, et al. (2023) Cancers (Basel), 15: 2331.
Ref. 218. Angajala A, et al. (2022) Sci Rep, 12: 22178.
Ref. 219. Zhao D, et al. (2022) Nat Commun, 13: 7734.
Ref. 220. Mani C, et al. (2023) Breast Cancer Res, 25: 44.
Ref. 221. Abu-Shihab Y, et al. (2023) Blood, 142: 722.
Ref. 222. Goncalves E, et al. (2022) Cancer Cell, 40: 835.
Ref. 223. Singhal SK, et al. (2022) JCI Insight, 7: e157465.
Ref. 224. Rodriguez H, et al. (2021) Cell, 184: 1661.
Ref. 225. Geffen Y, et al. (2023) Cell, 186: 3945.
Ref. 226. Lu Y, et al. (2020) Mol Cancer, 19: 79.
Ref. 227. Feil R, et al. (2012) Nat Rev Genet, 13: 97.
Ref. 228. Rasmussen L, et al. (2021) Nutrients, 13: 2821.
Ref. 229. Johnstone SE, et al. (2010) Nat Rev Genet, 11: 806.
Ref. 230. Ensenyat-Mendez M, et al. (2023) JAMA Netw Open, 6: e2335821.
Ref. 231. Jordan IK, et al. (2022) Oncoscience, 9: 23.
Ref. 232. Craddock J, et al. (2023) Cancers (Basel), 15: 3465.
Ref. 233. Gohar J, et al. (2022) Breast Cancer Res Treat, 191: 653.
Ref. 234. Miller-Kleinhenz JM, et al. (2023) Front Oncol, 13: 1154554.
Ref. 235. Jenkins BD, et al. (2023) JAMA Netw Open, 6: e2341651.
Ref. 236. Martin DN, et al. (2009) PLoS ONE, 4: e4531.
Ref. 237. Madu CO, et al (2020) J Cancer, 11: 4474.
Ref. 238. Kim G, et al. (2020) Front Oncol, 10: 1022.
Ref. 239. Nédélec Y, et al. (2016) Cell, 167: 657.
Ref. 240. Freedman JA, et al. (2021) Annual Review of Medicine, 72: 229.
Ref. 241. Kiely M, et al. (2022) Trends Cancer, 8: 316.
Ref. 242. Pichardo MS, et al. (2023) JAMA Netw Open, 6: e2251745.
Ref. 243. Kho ZY, et al. (2018) Front Microbiol, 9: 1835.
Ref. 244. Villemin C, et al. (2023) Trends Immunol, 44: 44.
Ref. 245. Byrd D, et al. (2024) Nat Rev Cancer, 24: 89.
Ref. 246. Piawah S, et al. (2023) Cancers (Basel), 15: 4546.
Ref. 247. Kyrgiou M, et al. (2022) Semin Cancer Biol, 86: 189.
Ref. 248. Sharifian K, et al. (2023) Virol J, 20: 73.
Ref. 249. Tossas KY, et al. (2023) J Womens Health (Larchmt), 32: 553.
Ref. 250. Chen Y, et al. (2022) Front Immunol, 13: 935846.
References 251-300
Ref. 251. Parida S, et al. (2023) NPJ Breast Cancer, 9: 4.
Ref. 252. Ahmad S, et al. (2022) World J Gastroenterol, 28: 2782.
Ref. 253. Mallott EK, et al. (2023) PLoS Biol, 21: e3002230.
Ref. 254. Mittal V (2018) Annu Rev Pathol, 13: 395.
Ref. 255. Dagogo-Jack I, et al. (2018) Nat Rev Clin Oncol, 15: 81.
Ref. 256. Lord BD, et al. (2022) Trends Cancer, 8: 276.
Ref. 257. Ma L, et al. (2022) Trends Cancer, 8: 286.
Ref. 258. Toal TW, et al. (2022) Cancer Res Commun, 2: 1487.
Ref. 259. Jin MZ, et al. (2020) Signal Transduct Target Ther, 5: 166.
Ref. 260. Anderson NM, et al. (2020) Curr Biol, 30: R921.
Ref. 261. Maynard JP, et al. (2022) Prostate, 82: 1505.
Ref. 262. Peres LC, et al. (2022) Cancer Epidemiol Biomarkers Prev, 31: 1006. Available from:
https://aacrjournals.org/cebp/article/31/5/1006/694742/Racial-Differences-in-the-Tumor-Immune-Landscape
Ref. 263. Zajac KK, et al. (2023) Cancer Rep (Hoboken), 6: e1779.
Ref. 264. Tang W, et al. (2018) Clin Cancer Res, 24: 5471. Available from:
https://aacrjournals.org/clincancerres/article/24/21/5471/281629/IFNL4-G-Allele-Is-Associated-with-an-Interferon
Ref. 265. Jenkins BD, et al. (2019) Cancer Epidemiol Biomarkers Prev, 28: 690. Available from:
https://aacrjournals.org/cebp/article/28/4/690/71949/Atypical-Chemokine-Receptor-1-DARC-ACKR1-in-Breast
Ref. 266. Wallace TA, et al. (2008) Cancer Res, 68: 927. Available from:
https://aacrjournals.org/cancerres/article/68/3/927/542012/Tumor-Immunobiological-Differences-in-Prostate
Ref. 267. Kumar B, et al. (2023) Nat Commun, 14: 5683.
Ref. 268. Bassiouni R, et al. (2023) Cancer Res, 83: 34. Available from:
https://aacrjournals.org/cancerres/article/83/1/34/711842/Spatial-Transcriptomic-Analysis-of-a-Diverse
Ref. 269. Bauer M, et al. (2023) Cancer Immunol Res, 11: 720. Available from:
https://aacrjournals.org/cancerimmunolres/article-abstract/11/6/720/726530/Regional-Variation-in-the-Tumor-Microenvironment
Ref. 270. Martini R, et al. (2022) Cancer Discov, 12: 2530. Available from:
https://aacrjournals.org/cancerdiscovery/article/12/11/2530/710001/African-Ancestry-Associated-Gene-Expression
Ref. 271. Holly JM, et al. (2013) Cancer Metastasis Rev, 32: 673.
Ref. 272. Castaneda M, et al. (2022) Semin Cancer Biol, 87: 17.
Ref. 273. Wang G, et al. (2021) NPJ Precis Oncol, 5: 56.
Ref. 274. Kinseth MA, et al. (2014) Int J Cancer, 134: 81.
Ref. 275. Awasthi S, et al. (2021) Clin Cancer Res, 27: 320. Available from:
https://aacrjournals.org/clincancerres/article/27/1/320/83232/Comparative-Genomics-Reveals-Distinct-Immune
Ref. 276. Liadi Y, et al. (2023) Prostate Cancer Prostatic Dis. DOI: 10.1038/s41391-023-00667-1.
Ref. 277. Halbert CH (2022) Annu Rev Genomics Hum Genet, 23: 613.
Ref. 278. Siddappa M, et al. (2023) Cancer Res Commun, 3: 621.
Ref. 279. Boyd AE, et al. (2023) Cancers (Basel), 15: 2238.
Ref. 280. Chavez-Yenter D, et al. (2022) JAMA Netw Open, 5: e2234574.
Ref. 281. American Association for Cancer Research. AACR Project GENIE. Accessed: March 17, 2024. Available from:
https://www.aacr.org/professionals/research/aacr-project-genie/news-updates/
Ref. 282. Goel N, et al. (2022) JAMA Network Open, 5: e220573.
Ref. 283. Kamran SC, et al. (2021) JCO Precis Oncol, 5: 1654
Ref. 284. Schumacher FR, et al. (2021) JCO Precis Oncol, 5: 1650.
Ref. 285. Public Health Institute. National RESPOND Study Takes Closer Look at Health Disparities in Prostate Cancer for African American Men. Accessed: April 22, 2024. Available from:
https://www.phi.org/about/impacts/national-respond-study-takes-closer-look-at-health-disparities-in-prostate-cancer-for-african-american-men/
Ref. 286. African American Prostate Cancer Study. What is RESPOND? Accessed: April 22, 2024. Available from:
https://respondstudy.org/StudyDetails.aspx
Ref. 287. Dutta R, et al. (2023) Nature Cancer, 4: 787.
Ref. 288. Khoury MJ, et al. (2022) Genet Med, 24: 1630.
Ref. 289. American Association for Cancer Research. AACR Cancer Progress Report 2022. Accessed: July 5, 2023. Available from:
https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2022/09/AACR_CPR_2022.pdf
Ref. 290. Pichardo MS, et al. (2022) Cancer, 128: 3630.
Ref. 291. Shams-White MM, et al. (2021) Prev Med Rep, 22: 101358.
Ref. 292. Heredia NI, et al. (2020) J Immigr Minor Health, 22: 555.
Ref. 293. American Forests. Tree Equity Score National Explorer. Accessed: March 26, 2024. Available from:
https://www.treeequityscore.org/map#11.36/39.9504/-75.1224
Ref. 294. Hajat A, et al. (2015) Curr Environ Health Rep, 2: 440.
Ref. 295. Boing AF, et al. (2022) JAMA Netw Open, 5: e2213540.
Ref. 296. Juon HS, et al. (2021) Prev Med, 143: 106355.
Ref. 297. Ferguson JM, et al. (2023) Chronobiol Int, 40: 310.
Ref. 298. Warren GW, et al. (2013) Am Soc Clin Oncol Educ Book. 2013:359
Ref. 299. Jha P, et al. (2013) N Engl J Med, 368: 341.
Ref. 300. Alexandrov LB, et al. (2016) Science, 354: 618.
References 301-350
Ref. 301. Pezzuto A, et al. (2019) Future Sci OA, 5: FSO394.
Ref. 302. Yang Y, et al. (2023) J Hazard Mater, 455: 131556.
Ref. 303. Cornelius ME, et al. (2023) MMWR Morb Mortal Wkly Rep, 72: 475.
Ref. 304. Arrazola RA, et al. (2023) Prev Chronic Dis, 20: E45.
Ref. 305. Loretan CG, et al. (2022) Prev Chronic Dis, 19: E87.
Ref. 306. Brody D, et al. (2021) MMWR Morb Mortal Wkly Rep, 70: 224.
Ref. 307. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Accessed: March 17, 2024. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK179276/
Ref. 308. American Lung Association. State of Lung Cancer 2023. Accessed: March 17, 2024. Available from:
https://www.lung.org/research/state-of-lung-cancer
Ref. 309. Williamson TJ, et al. (2020) Ann Behav Med, 54: 535.
Ref. 310. Diaz D, et al. (2022) Tob Induc Dis, 20: 38.
Ref. 311. Carter-Harris L (2015) J Am Assoc Nurse Pract, 27: 240.
Ref. 312. Cataldo JK, et al. (2012) Eur J Oncol Nurs, 16: 264.
Ref. 313. Siegel DA, et al. (2021) JAMA Oncol, 7: 302.
Ref. 314. Thomson B, et al. (2022) JAMA Netw Open, 5: e2231480.
Ref. 315. Ahmed AA, et al. (2015) Circ Heart Fail, 8: 694.
Ref. 316. Duncan MS, et al. (2019) JAMA, 322: 642.
Ref. 317. Watkins SL, et al. (2020) Nicotine Tob Res, 22: 1560.
Ref. 318. Babb S, et al. (2017) MMWR Morb Mortal Wkly Rep, 65: 1457.
Ref. 319. Flores MW, et al. (2024) J Racial Ethn Health Disp, 11: 755.
Ref. 320. Bittencourt L, et al. (2023) Nicotine Tob Res, ntad246.
Ref. 321. Zhang L, et al. (2019) Am J Prev Med, 57: 478.
Ref. 322. Wen KY, et al. (2023) J Racial Ethn Health Disp, DOI: 10.1007/s40615-023-01760-w.
Ref. 323. Presant CA, et al. (2023) J Clin Med, 12: 1275.
Ref. 324. Casas L, et al. (2023) Addict Behav Rep, 17: 100478.
Ref. 325. Tan ASL, et al. (2023) Am J Prev Med: 66: 840.
Ref. 326. Villanti AC, et al. (2021) Nicotine Tob Res, 23: 1318.
Ref. 327. Watkins SL, et al. (2022) J Adolesc Health, 71: 226.
Ref. 328. Villanti AC, et al. (2016) Tob Control, 25: ii14.
Ref. 329. Mendez D, et al. (2022) Nicotine Tob Control, 31: 569.
Ref. 330. Sawdey MD, et al. (2020) Nicotine Tob Res, 22: 1726.
Ref. 331. Birdsey J, et al. (2023) MMWR Morb Mortal Wkly Rep, 72: 1173.
Ref. 332. Park-Lee E, et al. (2022) MMWR Morb Mortal Wkly Rep, 71: 1429.
Ref. 333. Hu T, et al. (2020) J Am Heart Assoc, 9: e014381.
Ref. 334. Prochaska JJ, et al. (2022) Tob Control, 31: e88.
Ref. 335. National Academy of Sciences. Public health consequences of e-cigarettes. Accessed: July 6, 2023. Available from:
https://nap.nationalacademies.org/catalog/24952/public-health-consequences-of-e-cigarettes
Ref. 336. Do EK, et al. (2023) Prev Med Rep, 35: 102376.
Ref. 337. Erhabor J, et al. (2023) JAMA Netw Open, 6: e2340859.
Ref. 338. Goniewicz ML, et al. (2018) JAMA Netw Open, 1: e185937.
Ref. 339. Herbst RS, et al. (2022) Clin Cancer Res, 28: 4861. Available from:
https://aacrjournals.org/clincancerres/article/28/22/4861/710466/Electronic-Nicotine-Delivery-Systems-An-Updated
Ref. 340. Ghasemiesfe M, et al. (2019) JAMA Netw Open, 2: e1916318.
Ref. 341. Pew Research Center. Most Americans now live in a legal marijuana state – and most have at least one dispensary in their county. Accessed: March 26, 2024. Available from:
https://www.pewresearch.org/short-reads/2024/02/29/most-americans-now-live-in-a-legal-marijuana-state-and-most-have-at-least-one-dispensary-in-their-county/
Ref. 342. Islami F, et al. (2018) CA Cancer J Clin, 68: 31.
Ref. 343. Islami F, et al. (2019) JAMA Oncol, 5: 384.
Ref. 344. Centers for Disease Control and Prevention. Adult Obesity Facts. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/obesity/data/adult.html
Ref. 345. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Homepage. Accessed: March 26, 2024. Available from:
https://www.cdc.gov/nchs/nhanes/index.htm
Ref. 346. National Health Statistics Reports. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. Accessed: March 17, 2024. Available from:
https://stacks.cdc.gov/view/cdc/106273
Ref. 347. Jensen BW, et al. (2023) J Natl Cancer Inst, 115: 43.
Ref. 348. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files Development of Files and Prevalence Estimates for Selected Health Outcomes. In: National Center for Health S, editor. National Health Statistics Reports, NHSR No. 158. Hyattsville, MD; 2021. Available from:
http://dx.doi.org/10.15620/cdc:106273
Ref. 349. Centers for Disease Control and Prevention. Nutrition, Physical Activity, and Obesity: Data, Trends, and Maps. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html
Ref. 350. Pati S, et al. (2023) Cancers (Basel), 15: 485.
References 351-400
Ref. 351. Sung H, et al. (2019) Lancet Public Health, 4: e137.
Ref. 352. Zhao J, et al. (2023) BMJ Oncology, 2: e000049.
Ref. 353. Ullah F, et al. (2023) Cancers (Basel), 15: 3202.
Ref. 354. Hua H, et al. (2023) Front Oncol, 13: 1132306.
Ref. 355. Zaki TA, et al. (2023) Clin Gastroenterol Hepatol, 21: 497.
Ref. 356. Schauer DP, et al. (2017) Obesity (Silver Spring), 25 Suppl 2: S52.
Ref. 357. Bruno DS, et al. (2020) Ann Transl Med, 8: S13.
Ref. 358. Newton RL, Jr., et al. (2024) Obesity (Silver Spring), 32: 476.
Ref. 359. Saju R, et al. (2022) J Gen Intern Med, 37: 3715.
Ref. 360. Adams TD, et al. (2023) Obesity (Silver Spring), 31: 574.
Ref. 361. Aminian A, et al. (2022) JAMA, 327: 2423.
Ref. 362. Stone G, et al. (2022) Am J Surg, 223: 863.
Ref. 363. Tucker CM, et al. (2022) Clin Obes, 12: e12553.
Ref. 364. Morales-Berstein F, et al. (2024) Eur J Nutr, 63: 377.
Ref. 365. Jin Q, et al. (2023) Br J Cancer, 129: 1978.
Ref. 366. Chang K, et al. (2023) EClinicalMedicine, 56: 101840.
Ref. 367. Hang D, et al. (2023) J Natl Cancer Inst, 115: 155.
Ref. 368. National Center for Health Services. Fast food consumption among adults in the United States, 2013–2016. NCHS Data Brief, no 322. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/nchs/data/databriefs/db322-h.pdf
Ref. 369. US Department of Agriculture. Economic Research Service. Food Security Status of U.S. Households in 2022. Accessed: March 17, 2024. Available from:
https://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in-the-u-s/key-statistics-graphics/#foodsecure
Ref. 370. Taylor LC, et al. (2023) Med Res Arch, 11: DOI:10.18103/mra. v11i12.4593.
Ref. 371. Zhao L, et al. (2023) JAMA, 330: 537.
Ref. 372. Norman-Burgdolf H, et al. (2021) Prev Med Rep, 24: 101642.
Ref. 373. Hua SV, et al. (2023) Jama Network Open, 6: e2323200.
Ref. 374. Kaplan S, et al. (2024) JAMA Health Forum, 5: e234737.
Ref. 375. Bleich SN, et al. (2021) JAMA Netw Open, 4: e2113527.
Ref. 376. Lopez-Bueno R, et al. (2023) JAMA Intern Med, 183: 982.
Ref. 377. Minihan AK, et al. (2022) Med Sci Sports Exerc, 54: 417.
Ref. 378. Stamatakis E, et al. (2023) JAMA Oncol, 9: 1255.
Ref. 379. Piercy KL, et al. (2018) JAMA, 320: 2020.
Ref. 380. Withall J, et al. (2011) BMC Public Health, 11: 507.
Ref. 381. Patel NA, et al. (2022) Kans J Med, 15: 267.
Ref. 382. Engelberg JK, et al. (2016) BMC Public Health, 16: 395.
Ref. 383. Thornton CM, et al. (2016) SSM Popul Health, 2: 206.
Ref. 384. Centers for Disease Control and Prevention. Physical Inactivity is More Common among Racial and Ethnic Minorities in Most States. Accessed: July 5, 2023. Available from:
https://blogs.cdc.gov/healthequity/2020/04/01/physical-inactivity/
Ref. 385. Abildso CG, et al. (2023) MMWR Morb Mortal Wkly Rep, 72: 85.
Ref. 386. Rumgay H, et al. (2021) Lancet Oncol, 22: 1071.
Ref. 387. Goding Sauer A, et al. (2021) Cancer Epidemiol, 71: 101893.
Ref. 388. Statista. Current, binge, and heavy alcohol use in the past month in the United States in 2022, by race/ethnicity. Accessed: April 29, 2024. Available from:
https://www.statista.com/statistics/354291/current-binge-heavy-alcohol-use-in-persons-in-the-us-by-ethnicity/
Ref. 389. White AJ, et al. (2017) Am J Epidemiol, 186: 541.
Ref. 390. Cao Y, et al. (2015) BMJ, 351: h4238.
Ref. 391. Choi YJ, et al. (2018) Cancer Res Treat, 50: 474.
Ref. 392. Yoo JE, et al. (2021) JAMA Netw Open, 4: e2120382.
Ref. 393. Woodard N, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 261. Available from:
https://aacrjournals.org/cebp/article-abstract/33/2/261/733915/The-Association-between-State-Level-Structural
Ref. 394. Desalu JM, et al. (2019) Addiction,114: 957.
Ref. 395. Buckner JD, et al. (2023) J Racial Ethn Health Disp, 10: 987.
Ref. 396. Kong AY, et al. (2023) J Racial Ethn Health Disp, 10: 2861.
Ref. 397. Wu S, et al. (2014) Cancer Epidemiol Biomarkers Prev, 23: 1080. Available from:
https://aacrjournals.org/cebp/article/23/6/1080/70254/Long-term-Ultraviolet-Flux-Other-Potential-Risk
Ref. 398. Calderon TA, et al. (2019) Prev Med Rep, 13: 346.
Ref. 399. Zamil DH, et al. (2023) Dermatol Pract Concept, 13: e2023014.
Ref. 400. Harvey VM, et al. (2014) Cancer Control, 21: 343.
References 401-450
Ref. 401. Onamusi TA, et al. (2023) Arch Dermatol Res, 316: 32.
Ref. 402. Qian Y, et al. (2021) J Am Acad Dermatol, 84: 1585.
Ref. 403. Kim DY, et al. (2024) J Am Acad Dermatol, 90: 623.
Ref. 404. Blumenthal LY, et al. (2022) J Am Acad Dermatol, 86: 353.
Ref. 405. Kolla AM, et al. (2022) J Am Acad Dermatol, 87: 1220.
Ref. 406. Holman DM, et al. (2019) Journal of Community Health, 44: 1086.
Ref. 407. Skin Cancer Foundation. Indoor Tanning Legislation: Here’s Where We Stand. Accessed: July 5, 2023. Available from:
https://www.skincancer.org/blog/indoor-tanning-legislation-heres-stand/
Ref. 408. Chen R, et al. (2019) JAMA Netw Open, 2: e1912443.
Ref. 409. de Martel C, et al. (2020) Lancet Glob Health, 8: e180.
Ref. 410. National Cancer Institute. HPV and Cancer. Accessed: August 11, 2022. Available from:
https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer
Ref. 411. Hirth J (2019) Hum Vaccin Immunother, 15: 146.
Ref. 412. Wei F, et al. (2021) Lancet HIV, 8: e531.
Ref. 413. Chambers C, et al. (2023) J Infect Dis. 228: 89.
Ref. 414. Chidobem I, et al. (2022) Vaccines (Basel), 10: 604.
Ref. 415. Mix JM, et al. (2021) Cancer Epidemiol Biomarkers Prev, 30: 30. Available from:
https://aacrjournals.org/cebp/article/30/1/30/72426/Assessing-Impact-of-HPV-Vaccination-on-Cervical
Ref. 416. Pingali C, et al. (2022) MMWR Morb Mortal Wkly Rep, 71: 1101.
Ref. 417. Stephens ES, et al. (2023) JAMA Netw Open, 6: e2343325.
Ref. 418. Castaneda-Avila MA, et al. (2022) Hum Vaccin Immunother, 18: 2077065.
Ref. 419. Nadarzynski T, et al. (2021) Vaccine, 39: 3565.
Ref. 420. Klassen AC, et al. (2024) Vaccine, 42: 1704.
Ref. 421. Boucher JC, et al. (2023) BMC Public Health, 23: 694.
Ref. 422. Alhazmi H, et al. (2024) J Immigr Minor Health, 26: 117.
Ref. 423. Centers for Disease Control and Prevention. 2020 Hepatitis B. Viral Hepatitis Surveillance Report. Accessed: March 26, 2024. Available from:
https://www.cdc.gov/hepatitis/statistics/2020surveillance/hepatitis-b.htm
Ref. 424. Centers for Disease Control and Prevention. 2021 Viral Hepatitis Surveillance Report. Accessed: March 26, 2024. Available from:
https://www.cdc.gov/hepatitis/statistics/2021surveillance/index.htm
Ref. 425. National Center for Health Statistics. Prevalence and trends in hepatitis B virus infection in the United States, 2015–2018. NCHS Data Brief, no 361. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/nchs/data/databriefs/db361-h.pdf
Ref. 426. Razavi-Shearer D, et al. (2023) Lancet Reg Health Am, 22: 100516.
Ref. 427. Centers for Disease Control and Prevention. 2021 Viral Hepatitis Surveillance National Profile of Viral Hepatitis. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/hepatitis/statistics/2021surveillance/introduction/national-profile.htm
Ref. 428. Indian Health Service. Hepatitis C: Universal Screening and Treatment. Accessed: March 26, 2024. Available from:
https://www.ihs.gov/ihm/sgm/2019/hepatitis-c-universal-screening-and-treatment-19-02/
Ref. 429. Garman KS, et al. (2024) Gastric Cancer, 27: 28.
Ref. 430. Kumar S, et al. (2020) Gastroenterology, 158: 527.
Ref. 431. Lai Y, et al. (2022) Front Public Health, 10: 1056157.
Ref. 432. Monroy FP, et al. (2022) Diseases, 10: 19.
Ref. 433. Nolen LD, et al. (2018) Int J Circumpolar Health, 77: 1510715.
Ref. 434. Shah S, et al. (2023) Sci Rep, 13: 1375.
Ref. 435. Cordova-Marks FM, et al. (2022) Int J Environ Res Public Health, 19.
Ref. 436. Harris RB, et al. (2022) Int J Environ Res Public Health, 19: 797.
Ref. 437. Rolle-Kampczyk UE, et al. (2004) Int J Hyg Environ Health, 207: 363.
Ref. 438. US Global Change Research Program. Fourth National Climate Assessment. Volume II: Impacts, Risks, and Adaptation in the United States. Accessed: March 17, 2024. Available from:
https://nca2018.globalchange.gov/downloads/NCA2018_FullReport.pdf
Ref. 439. Lopez AM, et al. (2023) Nat Commun, 14: 8007.
Ref. 440. Yazzie SA, et al. (2020) Int J Environ Res Public Health, 17: 2813.
Ref. 441. US Environmental Protection Agency. Abandoned Mines Cleanup. Accessed: March 17, 2024. Available from:
https://www.epa.gov/navajo-nation-uranium-cleanup/abandoned-mines-cleanup
Ref. 442. Collins MB, et al. (2016) Environ Res Lett, 11: 015004.
Ref. 443. Johnston J, et al. (2020) Curr Environ Health Rep, 7: 48.
Ref. 444. Jephcote C, et al. (2020) Environ Health, 19: 53.
Ref. 445. van Gerwen M, et al. (2023) EBioMedicine, 97: 104831.
Ref. 446. Liu H, et al. (2023) Front Oncol, 13: 1282651.
Ref. 447. Cheng I, et al. (2022) Am J Respir Crit Care Med, 206: 1008.
Ref. 448. Carroll R, et al. (2023) Environ Res, 239: 117349.
Ref. 449. Chang CJ, et al. (2022) J Natl Cancer Inst, 114: 1636.
Ref. 450. Bertrand KA, et al. (2023) Environ Res, 239: 117228.
References 451-500
Ref. 451. Llanos AAM, et al. (2017) Carcinogenesis, 38: 883.
Ref. 452. Morris RD (1995) Environ Health Perspect, 103 Suppl 8: 225.
Ref. 453. VanDerslice J (2011) Am J Public Health, 101 Suppl 1: S109.
Ref. 454. Tanana H, et al. (2021) Health Secur, 19: S78.
Ref. 455. Wroblewski LE, et al. (2010) Clin Microbiol Rev, 23: 713.
Ref. 456. Liddie JM, et al. (2023) Environ Sci Tech, 57: 7902.
Ref. 457. Loomis D, et al. (2013) Lancet Oncol, 14: 1262.
Ref. 458. American Lung Association. State of the Air 2023. Accessed: July 5, 2023. Available from:
https://www.lung.org/research/sota
Ref. 459. Shen J, et al. (2017) Br J Cancer, 116: 1229.
Ref. 460. Korsh J, et al. (2015) Breast Care (Basel), 10: 316.
Ref. 461. American Lung Association. State of the Air 2023 Report. Accessed: March 17, 2024. Available from:
https://www.lung.org/getmedia/338b0c3c-6bf8-480f-9e6e-b93868c6c476/SOTA-2023.pdf
Ref. 462. Bradley AC, et al. (2024) Environ Sci Technol, DOI: 10.1021/acs. est.3c03230.
Ref. 463. Tessum CW, et al. (2021) Sci Adv, 7: eabf4491.
Ref. 464. Bonner SN, et al. (2024) JAMA Oncol, 10: 122.
Ref. 465. Calvert GM, et al. (2012) Am J Ind Med, 55: 412.
Ref. 466. McHugh MK, et al. (2010) Cancer Causes Control, 21: 2157.
Ref. 467. Ashing KT, et al. (2022) JCO Oncol Pract, 18: 15.
Ref. 468. Tsai RJ, et al. (2015) Am J Ind Med, 58: 715.
Ref. 469. Goodrich JM, et al. (2021) Epigenet Insights, 14:25168657211006159.
Ref. 470. Lee DJ, et al. (2023) Front Oncol, 13: 1130754.
Ref. 471. Kunz KR, et al. (2023) Front Public Health, 11: 1126066.
Ref. 472. Dahm MM, et al. (2015) Occup Environ Med, 72: 670.
Ref. 473. Pinkerton L, et al. (2020) Occup Environ Med, 77: 84.
Ref. 474. Daniels RD, et al. (2015) Occup Environ Med, 72: 699.
Ref. 475. Daniels RD, et al. (2014) Occup Environ Med, 71: 388.
Ref. 476. Kang D, et al. (2008) Am J Ind Med, 51: 329.
Ref. 477. Centers for Disease Control and Prevention. Findings from a Study of Cancer Among U.S. Fire Fighters. Accessed: March 30, 2024. Available from:
https://stacks.cdc.gov/view/cdc/40710
Ref. 478. IARC Working Group on the Identification of Carcinogenic Hazards to Humans. Night Shift Work. Accessed: March 17, 2024. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK568199/
Ref. 479. Huang C, et al. (2023) Cancer Biol Med, 20: 1.
Ref. 480. Sahin L, et al. (2022) LR & T, 54: 441.
Ref. 481. Figueiro MG, et al. (2010) Int J Endocrinol, 2010: 829351.
Ref. 482. Faraut B, et al. (2019) Front Neurosci, 13: 1366.
Ref. 483. Skinner HG, et al. (2024) J Am Geriatr Soc, 72: 349.
Ref. 484. Lawrence WR, et al. (2023) Cancer Prev Res (Phila), 16: 259. Available from:
https://aacrjournals.org/cancerpreventionresearch/article/16/5/259/725942/Stressful-Life-Events-Social-Support-and-Incident
Ref. 485. Sanchez-Diaz CT, et al. (2021) Cancer Causes Control, 32: 357.
Ref. 486. Mazor M, et al. (2021) Psychooncology, 30: 1789.
Ref. 487. Garrett E, et al. (2024) J Natl Cancer Inst, 116: 258.
Ref. 488. Obeng-Gyasi S, et al. (2023) JAMA Netw Open, 6: e2313989.
Ref. 489. Guan Y, et al. (2023) Breast Cancer Res, 25: 155.
Ref. 490. Obeng-Gyasi S, et al. (2022) JAMA Netw Open, 5: e2221626.
Ref. 491. Parker HW, et al. (2022) Am J Prev Med, 63: 131.
Ref. 492. Li C, et al. (2023) BMC Womens Health, 23: 448.
Ref. 493. Moore JX, et al. (2022) SSM Popul Health, 19: 101185.
Ref. 494. Andrzejak SE, et al. (2023) Am J Prev Med, 65: 417.
Ref. 495. Bodewes FTH, et al. (2022) Breast, 66: 62.
Ref. 496. Kerlikowske K, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 1524. Available from:
https://aacrjournals.org/cebp/article-abstract/32/11/1524/729734/Impact-of-BMI-on-Prevalence-of-Dense-Breasts-by
Ref. 497. Henschke CI, et al. (2023) Radiology, 309: e231988.
Ref. 498. Philipson TJ, et al. (2023) BMC Health Serv Res, 23: 829.
Ref. 499. Knudsen AB, et al. (2023) JAMA Netw Open, 6: e2344698.
Ref. 500. Harris RP, et al. (2014) JAMA Intern Med, 174: 281.
References 501-550
Ref. 501. Kamineni A, et al. (2022) Ann Intern Med, 175: 1582.
Ref. 502. Mak J (2023) J Natl Compr Canc Netw, 21: 430.
Ref. 503. Silvestri GA, et al. (2023) Chest, 164: 241.
Ref. 504. Munir MM, et al. (2023) J Surg Oncol, 127: 1212.
Ref. 505. Kim RY, et al. (2022) Ann Am Thorac Soc, 19: 1561.
Ref. 506. Khan MMM, et al. (2024) Ann Surg Oncol, 31: 911.
Ref. 507. Oh KM, et al. (2023) Cancer Causes Control, 34: 813.
Ref. 508. Pena MA, et al. (2023) J Am Coll Radiol, 20: 642.
Ref. 509. Sabatino SA, et al. (2023) Prev Chronic Dis, 20: E94.
Ref. 510. Lei F, et al. (2023) Cancer Control, 30: 10732748231202462.
Ref. 511. Chen T, et al. (2023) JAMA Netw Open, 6: e238893.
Ref. 512. United States Preventive Services Taskforce. Draft Recommendation: Breast Cancer: Screening. Accessed: July 5, 2023. Available from:
https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/breast-cancer-screening-adults
Ref. 513. Fayanju OM, et al. (2023) Ann Surg Oncol, 30: 58.
Ref. 514. Wilkerson AD, et al. (2023) Ann Surg Oncol, 30: 2856.
Ref. 515. Ponce-Chazarri L, et al. (2023) Cancers (Basel), 15: 604.
Ref. 516. La Frinere-Sandoval Q, et al. (2023) Ethn Health, 28: 895.
Ref. 517. Heer E, et al. (2023) Prev Med, 170: 107478.
Ref. 518. Ganguly AP, et al. (2023) Cancer, 129: 3171.
Ref. 519. Liu Z, et al. (2024) Geriatr Nurs, 55: 14.
Ref. 520. Sokale IO, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 82. Available from:
https://aacrjournals.org/cebp/article/32/1/82/712611/Trends-and-Racial-Ethnic-Differences-in-Predictors
Ref. 521. Lin E, et al. (2024) Cancer Causes Control, 35: 133.
Ref. 522. Orji AF, et al. (2024) Am J Prev Med, 66: 83.
Ref. 523. National Association of Community Health Centers. Community Health Center Chartbook 2020. Accessed: March 17, 2024. Available from:
https://www.nachc.org/wp-content/uploads/2020/01/Chartbook-2020-Final.pdf
Ref. 524. Springer R, et al. (2024) SSM Popul Health, 25: 101612.
Ref. 525. Khoong EC, et al. (2023) J Gen Intern Med, 38: 21.
Ref. 526. Kane WJ, et al. (2023) Dis Colon Rectum, 66: 1223.
Ref. 527. Ouni A, et al. (2023) Journal of Clinical Oncology, 41: 18.
Ref. 528. Mehta SJ, et al. (2021) JAMA Netw Open, 4: e2112593.
Ref. 529. Santiago-Rodriguez EJ, et al. (2023) Am J Prev Med, 65: 74.
Ref. 530. Rutter CM, et al. (2023) J Natl Cancer Inst Monogr, 2023: 196.
Ref. 531. Aberle DR, et al. (2011) N Engl J Med, 365: 395.
Ref. 532. de Koning HJ, et al. (2020) N Engl J Med, 382: 503.
Ref. 533. Kunitomo Y, et al. (2022) Chest, 161: 266.
Ref. 534. Ritzwoller DP, et al. (2021) JAMA Netw Open, 4: e2128176.
Ref. 535. Pu CY, et al. (2022) JAMA Oncol, 8: 374.
Ref. 536. Aredo JV, et al. (2022) JNCI Cancer Spectr, 6.
Ref. 537. Choi E, et al. (2023) JAMA Oncol, 9: 1640.
Ref. 538. Oshiro CES, et al. (2022) JAMA Netw Open, 5: e2144381.
Ref. 539. Navuluri N, et al. (2023) JAMA Netw Open, 6: e2318795.
Ref. 540. Kim RY, et al. (2023) Am J Respir Crit Care Med, 207: 777.
Ref. 541. National Cancer Institute. Cancer Treads Progress Reports. Prostate Cancer Screening. Accessed: March 17, 2024. Available from:
https://progressreport.cancer.gov/detection/prostate_cancer
Ref. 542. Bryant AK, et al. (2022) JAMA Oncol, 8: 1747.
Ref. 543. Schafer EJ, et al. (2023) Eur Urol, 84: 117.
Ref. 544. Oren O, et al. (2016) J Clin Oncol, 34: e18057.
Ref. 545. Kensler KH, et al. (2024) J Natl Cancer Inst, 116: 34.
Ref. 546. Premo H, et al. (2023) Urology, 176: 237.
Ref. 547. Kalavacherla S, et al. (2024) JAMA Netw Open, 7: e2356088.
Ref. 548. McCormick ME, et al. (2023) J Cancer Educ, 38: 1313.
Ref. 549. Frego N, et al. (2024) Am J Prev Med, 66: 27.
Ref. 550. Korn AR, et al. (2023) CA Cancer J Clin, 73: 461.
References 551-600
Ref. 551. Subramanian S, et al. (2022) Implement Sci Commun, 3: 110.
Ref. 552. Centers for Disease Control and Prevention. Colorectal Cancer Control Program. Award Recipient Highlights. Accessed: March 17, 2024. Available from: https://www.cdc.gov/cancer/crccp/success/
Ref. 553. Shi KS, et al. (2023) JCO Oncol Pract, 19: 116.
Ref. 554. Ercia A (2021) BMC Health Serv Res, 21: 920.
Ref. 555. Qian Z, et al. (2023) Dig Dis Sci, 68: 1780.
Ref. 556. Ma GX, et al. (2022) Cancer Control, 2022: 29.
Ref. 557. National Cancer Institute. Screen to Save -Colorectal Cancer Screening. Accessed: March 17, 2024. Available from:
https://www.cancer.gov/about-nci/organization/crchd/inp/screen-to-save
Ref. 558. Richardson-Parry A, et al. (2023) J Racial Ethn Health Disparities. Availalble from:
https://doi.org/10.1007/s40615-023-01749-5
Ref. 559. Wyatt LC, et al. (2023) J Cancer Educ, 38: 682.
Ref. 560. Maybee W, et al. (2024) J Cancer Educ, 39: 65.
Ref. 561. Gay NA, et al. (2023) J Clin Oncol, 41: 6518.
Ref. 562. Ginzberg SP, et al. (2023) Acad Radiol, 30: 3153.
Ref. 563. Atlas SJ, et al. (2023) JAMA, 330: 1348.
Ref. 564. Glaser KM, et al. (2024) Int J Environ Res Public Health, 21.
Ref. 565. Henderson LM, et al. (2023) JAMA Netw Open, 6: e2320409.
Ref. 566. Sengupta R, et al. (2019) Clin Cancer Res, 25: 5431. Available from:
https://aacrjournals.org/clincancerres/article/25/18/5431/81861/AACR-Cancer-Progress-Report-2019-Transforming
Ref. 567. Abu Rous F, et al. (2024) JAMA Oncol, 10: 416.
Ref. 568. Duenas JAC, et al. (2023) BMC Cancer, 23: 786.
Ref. 569. Koo KC, et al. (2018) BMC Cancer, 18: 468.
Ref. 570. Arfe A, et al. (2023) J Natl Cancer Inst, 115: 917.
Ref. 571. Shadbolt C, et al. (2023) JAMA Netw Open, 6: e2250996.
Ref. 572. Adashek JJ, et al. (2019) Nat Rev Clin Oncol, 16: 773.
Ref. 573. Kingwell K (2022) Nat Rev Drug Discov, 21: 702.
Ref. 574. Unger JM (2023) JAMA Netw Open, 6: e2322436.
Ref. 575. Mesa R, et al. (2023) Trans Am Clin Climatol Assoc, 133: 149.
Ref. 576. Loehrer AP, et al. (2024) Hematol Oncol Clin North Am, 38: 1.
Ref. 577. In: Bibbins-Domingo K, Helman A, editors. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. Washington (DC)2022.
Ref. 578. Wong AK, et al. (2023) JAMA, 330: 2392.
Ref. 579. Monge C, et al. (2023) Cancer Med, 13: e6814.
Ref. 580. Green AK, et al. (2022) JAMA Oncol, 8: 1786.
Ref. 581. Gopishetty S, et al. (2020) Am J Transl Res, 12: 5977.
Ref. 582. Muffly L, et al. (2022) Blood Adv, 6: 4085.
Ref. 583. Pittell H, et al. (2023) JAMA Netw Open, 6: e2322515.
Ref. 584. Saez-Ibanez AR, et al. (2022) Nat Rev Drug Discov, 21: 870.
Ref. 585. Khadraoui W, et al. (2023) JAMA Netw Open, 6: e2346494.
Ref. 586. Riaz IB, et al. (2023) JAMA Oncol, 9: 180.
Ref. 587. Earl ER, et al. (2023) Neurooncol Pract, 10: 472.
Ref. 588. DeCormier Plosky W, et al. (2022) Health Aff (Millwood), 41: 1423.
Ref. 589. Zhao S, et al. (2024) BMC Cancer, 24: 30.
Ref. 590. Kanapuru B, et al. (2022) Blood Adv, 6: 1684.
Ref. 591. Rosser BRS, et al. (2023) J Clin Oncol, 41: 5093.
Ref. 592. Donzo MW, et al. (2024) Cancer Med, 13.
Ref. 593. Roth M, et al. (2021) Cancer Med, 10: 7620.
Ref. 594. IQVIA. Global Trends in R&D 2023. Accessed: March 17, 2024. Available from:
https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023
Ref. 595. Dunlop H, et al. (2022) JAMA Netw Open, 5: e2239884.
Ref. 596. Varma T, et al. (2023) BMJ Med, 2: e000395.
Ref. 597. Center for Drug Evaluation and Research. Drug Trials Snapshots Summary Report 2022. Accessed: March 17, 2024. Available from:
https://www.fda.gov/media/168662/download
Ref. 598. Centers for Disease Control and Prevention. Cancer Trends. Accessed: March 27, 2024. Available from:
https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/Trends/
Ref. 599. Casey M, et al. (2023) Blood, 142: 846.
Ref. 600. Akimoto K, et al. (2023) Cancer J, 29: 310.
References 601-650
Ref. 601. NIH Office of Research on Women’s Health. Review of the Literature: Primary Barriers and Facilitators to Participation in Clinical Research. Accessed: March 17, 2024. Available from:
https://orwh.od.nih.gov/sites/orwh/files/docs/orwh_outreach_toolkit_litreview.pdf
Ref. 602. Metastatic Breast Cancer Alliance. BECOME (Black Experience of Clinical Trials and Opportunities for Meaningful Engagement) Research Report. Accessed: March 17, 2024. Available from:
https://www.mbcalliance.org/wp-content/uploads/BECOME-Final-Report-FULL.pdf
Ref. 603. Unger JM, et al. (2021) J Natl Cancer Inst, 113: 244.
Ref. 604. Hernandez ND, et al. (2021) J Cancer Educ, 37: 1589
Ref. 605. Overcoming Barriers for Latinos on Cancer Clinical Trials. Accessed: April 22, 2022. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK573233/
Ref. 606. Aristizabal P, et al. (2021) JAMA Network Open, 4: e219038.
Ref. 607. Reopell L, et al. (2023) PLoS One, 18: e0281940.
Ref. 608. Coley AK, et al. (2023) JCO Oncol Pract, 19: 154.
Ref. 609. Andac-Jones E, et al. (2023) J Clin Oncol, 41: e18675.
Ref. 610. Barrett NJ, et al. (2023) JCO Oncol Pract, 19: e570.
Ref. 611. Paydary K, et al. (2023) JAMA Oncol, 9: 863.
Ref. 612. Unger JM, et al. (2021) J Clin Oncol, 39: 1339.
Ref. 613. Lipsyc-Sharf M, et al. (2023) JAMA Netw Open, 6: e2339584.
Ref. 614. Riner AN, et al. (2022) J Clin Oncol, 40: 2193.
Ref. 615. Kanapuru B, et al. (2023) Blood, 142: 235.
Ref. 616. Riner AN, et al. (2023) JNCI Cancer Spectr, 7.
Ref. 617. Caston NE, et al. (2022) JCO Oncol Pract, 18: e1854.
Ref. 618. Alqazaqi R, et al. (2022) JAMA Netw Open, 5: e2228877.
Ref. 619. Harvey RD, et al. (2024) Cancer, 130: 1193.
Ref. 620. Mulligan KM, et al. (2023) Arch Dermatol Res, 315: 1033.
Ref. 621. Fashoyin-Aje LA, et al. (2024) JAMA Oncol, 10: 380.
Ref. 622. Umaretiya PJ, et al. (2023) JAMA Netw Open, 6: e2346814.
Ref. 623. Guo XM, et al. (2024) Gynecol Oncol, 180: 86.
Ref. 624. Velez MA, et al. (2023) Nature, 620: 855.
Ref. 625. Aristizabal P, et al. (2023) JAMA Netw Open, 6: e2346858.
Ref. 626. Odedina FT, et al. (2024) Mayo Clin Proc, 99: 159.
Ref. 627. Budhu JA, et al. (2023) Neuro Oncol: noad242.
Ref. 628. Oyer RA, et al. (2022) J Clin Oncol, 40: 2163.
Ref. 629. Fashoyin-Aje LA, et al. (2023) Clin Cancer Res, 29: 3566. Available from:
https://aacrjournals.org/clincancerres/article/29/18/3566/728902/Driving-Diversity-and-Inclusion-in-Cancer-Drug
Ref. 630. Loeb S, et al. (2023) JAMA Netw Open, 6: e2324395.
Ref. 631. Kuri L, et al. (2023) Clin Trials, 20: 585.
Ref. 632. An J, et al. (2023) Cancer: 1–17.
Ref. 633. Guerra CE, et al. (2021) Journal of Clinical Oncology, 39: 100.
Ref. 634. Mainous AG, 3rd, et al. (2023) Ann Fam Med, 21: 54.
Ref. 635. Strom C, et al. (2024) North Carolina Med J, 85: 0.
Ref. 636. Hall AG, et al. (2023) Transplant Cell Ther, 29: 356 e1.
Ref. 637. Badr H, et al. (2023) Cancer Cell, 41: 2007.
Ref. 638. Kanapuru B, et al. (2017) J Clin Oncol, 35: 2539.
Ref. 639. Acoba JD, et al. (2022) Contemp Clin Trials Commun, 28: 100933.
Ref. 640. Eggly S, et al. (2023) Cancer Med, 12: 8604.
Ref. 641. Varma T, et al. (2023) JAMA Oncol, 9: 765.
Ref. 642. Cullen MR, et al. (2023) Contemp Clin Trials, 129: 107184.
Ref. 643. Bushueva NN (1989) Oftalmol Zh, 4: 194.
Ref. 644. Grant MJ, et al. (2023) Nat Med, 29: 1908.
Ref. 645. Hwang TJ, et al. (2022) N Engl J Med, 387: 1347.
Ref. 646. U.S. Food and Drug Administration. Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry; Availability. Accessed: March 17, 2024. Available from:
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations
Ref. 647. US Food and Drug Administration. Project Equity. Accessed: March 17, 2024. Available from:
https://www.fda.gov/media/174160/download
Ref. 648. American Association for Cancer Research. AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care. Accessed: June 30, 2022. Available from:
https://cancerprogressreport.aacr.org/covid/c19c-contents/
Ref. 649. Unger JM, et al. (2023) JAMA Oncol, 9: 1371.
Ref. 650. Dahne J, et al. (2023) JAMA, 329: 2013.
References 651-700
Ref. 651. Ubbaonu CD, et al. (2023) Cancers (Basel), 15: 5586.
Ref. 652. Winn R, et al. (2023) J Natl Med Assoc, 115: S2.
Ref. 653. Obeng-Gyasi S, et al. (2023) J Racial Ethn Health Disp, DOI: 10.1007/s40615-023-01788-y.
Ref. 654. Yousefi Nooraie R, et al. (2022) Front Health Serv, 2: 1113916.
Ref. 655. Sheni R, et al. (2023) JCO Oncol Pract, 19: e904.
Ref. 656. Schatz AA, et al. (2022) J Natl Compr Canc Netw, 20: 1092.
Ref. 657. Navarro S, et al. (2023) J Natl Compr Canc Netw, 22: e237074.
Ref. 658. Wagle NS, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 463. Available from:
https://aacrjournals.org/cebp/article-abstract/33/4/463/742084/Racial-and-Ethnic-Disparities-in-Hepatocellular
Ref. 659. Guadamuz JS, et al. (2023) JNCI Cancer Spectr, 7: pkad058.
Ref. 660. Hougen HY, et al. (2023) JCO Oncol Pract, 19: 645.
Ref. 661. Elshami M, et al. (2023) HPB (Oxford), 25: 1502.
Ref. 662. Lima HA, et al. (2023) Ann Surg Oncol, 30: 4363.
Ref. 663. Liu X, et al. (2023) JAMA Netw Open, 6: e2251524.
Ref. 664. Chen DW, et al. (2023) J Natl Compr Canc Netw, 21: 951.
Ref. 665. Obrochta CA, et al. (2022) PLoS One, 17: e0272076.
Ref. 666. Llanos AAM, et al. (2023) JAMA Netw Open, 6: e2251165.
Ref. 667. Okado I, et al. (2022) J Clin Oncol, 40: 132.
Ref. 668. Chen S, et al. (2023) Front Public Health, 11: 1265071.
Ref. 669. Rock C, et al. (2023) JNCI Cancer Spectr, 7: pkad032.
Ref. 670. Reeder-Hayes KE, et al. (2023) Cancer, 129: 925.
Ref. 671. Pandit AA, et al. (2023) Cancers (Basel), 15: 1939.
Ref. 672. Bregio C, et al. (2022) JCO Oncol Pract, 18: e1885.
Ref. 673. Takeshita J, et al. (2020) JAMA Netw Open, 3: e2024583.
Ref. 674. Russell S, et al. (2022) Clin J Oncol Nurs, 26: 183.
Ref. 675. Chan ASW, et al. (2023) Soc Work Health Care, 62: 263.
Ref. 676. Kamen CS, et al. (2023) JCO Oncol Pract, 19: 959.
Ref. 677. Zahnd WE, et al. (2021) Int J Environ Res Pub Health, 18: 1384.
Ref. 678. Dong J, et al. (2022) Blood Cancer J, 12: 34.
Ref. 679. Gong J, et al. (2024) J Clin Oncol, 42: 228.
Ref. 680. Lam MB, et al. (2020) JAMA Netw Open, 3: e2027415.
Ref. 681. Stabellini N, et al. (2023) Sci Rep, 13: 1233.
Ref. 682. Fwelo P, et al. (2023) Breast Cancer Res Treat, 199: 511.
Ref. 683. Howard R, et al. (2023) Ann Surg, 278: e51.
Ref. 684. Balakrishnan A, et al. (2023) Ethn Health, 28: 1103.
Ref. 685. Schoephoerster J, et al. (2023) J Thorac Dis, 15: 5891.
Ref. 686. Jain B, et al. (2023) Ann Surg Oncol, 30: 5495.
Ref. 687. Molina G, et al. (2023) JAMA Netw Open, 6: e230797.
Ref. 688. Ramapriyan R, et al. (2023) Neurosurg Focus, 55: E12.
Ref. 689. Olecki EJ, et al. (2024) J Surg Res, 294: 160.
Ref. 690. Halloran SJ, et al. (2023) Curr Oncol, 30: 2801.
Ref. 691. Mao J, et al. (2024) Cancer Epidemiol Biomarkers Prev, 33: 20. Available from:
https://aacrjournals.org/cebp/article-abstract/33/1/20/732007/Racial-and-Ethnic-Disparities-in-the-Use-of-Robot
Ref. 692. Sakowitz S, et al. (2023) J Thorac Cardiovasc Surg, 165: 1577.
Ref. 693. Childers CP, et al. (2023) Ann Surg Oncol, 30: 3560.
Ref. 694. Tang C, et al. (2021) Int J Radiat Oncol Biol Phys, 109: 1286.
Ref. 695. Honaker MD, et al. (2023) Ann Surg Oncol, 30: 3547.
Ref. 696. Logan CD, et al. (2023) J Surg Res, 283: 1053.
Ref. 697. Brooks GA, et al. (2023) J Natl Cancer Inst, 115: 1171.
Ref. 698. Ramkumar N, et al. (2022) JAMA Netw Open, 5: e2229247.
Ref. 699. Ghauri MS, et al. (2023) Cureus, 15: e37112.
Ref. 700. Sebastian N, et al. (2023) JAMA Netw Open, 6: e2327637.
References 701-750
Ref. 701. Khalil M, et al. (2024) Ann Surg Oncol, 31: 1477.
Ref. 702. Nyame YA, et al. (2023) Cancer, 129: 1402.
Ref. 703. Chen SY, et al. (2023) Surgery, 174: 1323.
Ref. 704. Bassiri A, et al. (2024) J Surg Res, 293: 248.
Ref. 705. Samuel D, et al. (2023) Gynecol Oncol, 174: 1.
Ref. 706. Broekhuis JM, et al. (2023) JAMA Surg, 158: 111.
Ref. 707. Morrow M, et al. (2022) Ann Surg Oncol, 29: 2136.
Ref. 708. Maroongroge S, et al. (2022) Int J Radiat Oncol Biol Phys, 112: 600.
Ref. 709. Delaney G, et al. (2005) Cancer, 104: 1129.
Ref. 710. Chierchini S, et al. (2019) Cancer Manag Res, 11: 8829.
Ref. 711. Sengupta R, et al. (2020) Clin Cancer Res, 26: 5055. Available from:
https://aacrjournals.org/clincancerres/article/26/19/5055/82687/AACR-Cancer-Progress-Report-2020-Turning-Science
Ref. 712. American Association for Cancer Research. AACR Cancer Progress Report 2018. Accessed: June 30, 2022. Available from:
https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2020/09/AACR_CPR_2018.pdf
Ref. 713. Hamdy FC, et al. (2023) N Engl J Med, 388: 1547.
Ref. 714. Cooperberg MR, et al. (2023) JAMA Netw Open, 6: e231439.
Ref. 715. Chen AM (2023) Front Health Serv, 3: 1288329.
Ref. 716. Verdini NP, et al. (2024) Am J Clin Oncol, 47: 40.
Ref. 717. Gardner U, Jr., et al. (2022) Adv Radiat Oncol, 7: 100943.
Ref. 718. Taparra K, et al. (2023) Cancers (Basel), 15: 2571.
Ref. 719. Chen AM, et al. (2023) Oral Oncol, 147: 106611.
Ref. 720. Diao K, et al. (2024) Int J Radiat Oncol Biol Phys, 118: 626.
Ref. 721. Niazi TM, et al. (2022) Int J Radiat Oncol Biol Phys, 114: S3.
Ref. 722. Haviland JS, et al. (2013) Lancet Oncol, 14: 1086.
Ref. 723. Avkshtol V, et al. (2020) J Clin Oncol, 38: 1676.
Ref. 724. Lamm R, et al. (2022) Surgery, 172: 31.
Ref. 725. Dee EC, et al. (2023) JCO Oncol Pract, 19: e197.
Ref. 726. Ganesh A, et al. (2023) Clin Lung Cancer, 24: 60.
Ref. 727. Qureshy SA, et al. (2023) JAMA Netw Open, 6: e2337165.
Ref. 728. Liu Q, et al. (2024) Cancer Epidemiol Biomarkers Prev: , 33: 489. Available from:
https://aacrjournals.org/cebp/article-abstract/33/4/489/742082/Trends-and-Disparities-in-Curative-Intent
Ref. 729. Beckett M, et al. (2023) JCO Glob Oncol, 9: e2300130.
Ref. 730. Arega MA, et al. (2021) J Clin Oncol, 39: 24.
Ref. 731. LaVigne AW, et al. (2023) Int J Radiat Oncol Biol Phys, 116: 17.
Ref. 732. Lui G, et al. (2022) Adv Radiat Oncol, 7: 101017.
Ref. 733. Amiri S, et al. (2022) Value Health, 25: 1929.
Ref. 734. DeVita VT, Jr., et al. (2008) Cancer Res, 68: 8643. Available from:
https://aacrjournals.org/cancerres/article/68/21/8643/541799/A-History-of-Cancer-Chemotherapy
Ref. 735. East P, et al. (2022) Nat Commun, 13: 5632.
Ref. 736. Rais R, et al. (2022) Sci Adv, 8: eabq5925.
Ref. 737. Kotani D, et al. (2023) Nat Med, 29: 127.
Ref. 738. Jabbal IS, et al. (2023) Cancers (Basel), 15.
Ref. 739. Nogueira LM, et al. (2023) J Clin Oncol: JCO2300539.
Ref. 740. Siegel RL, et al. (2023) CA Cancer J Clin, 73: 233.
Ref. 741. Giannakis M, et al. (2023) Science, 379: 1088.
Ref. 742. El Hajj J, et al. (2022) Clin Colorectal Cancer, 21: 315.
Ref. 743. Rashid Z, et al. (2024) J Surg Oncol, 129: 850.
Ref. 744. Lee SS, et al. (2024) Gynecol Oncol, 182: 132.
Ref. 745. Rosenzweig MQ, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 157. Available from:
https://aacrjournals.org/cebp/article/32/2/157/716376/Racial-Differences-in-Breast-Cancer-Therapeutic
Ref. 746. Pathak S, et al. (2023) Cancer Rep (Hoboken), 6 Suppl 1: e1830.
Ref. 747. Zhao F, et al. (2023) JAMA Netw Open, 6: e233329.
Ref. 748. Shubeck S, et al. (2023) JAMA Netw Open, 6: e235834.
Ref. 749. Hoskins KF, et al. (2021) JAMA Oncology, 7: 370.
Ref. 750. Collin LJ, et al. (2019) NPJ Breast Cancer, 5: 32.
References 751-800
Ref. 751. Sood N, et al. (2022) JAMA Netw Open, 5: e2225345.
Ref. 752. Hu X, et al. (2022) JAMA Netw Open, 5: e2225485.
Ref. 753. Herbach EL, et al. (2023) Cancer Epidemiol Biomarkers Prev, 32: 1312. Available from:
https://aacrjournals.org/cebp/article-abstract/32/10/1312/729172/Patterns-of-Evidence-Based-Care-for-the-Diagnosis
Ref. 754. Goyal RK, et al. (2023) Cancer, 129: 1051.
Ref. 755. Neven P, et al. (2023) Breast Cancer Res, 25: 103.
Ref. 756. Sathe C, et al. (2023) Breast Cancer Res Treat, 200: 85.
Ref. 757. Ma TM, et al. (2023) JAMA Netw Open, 6: e2345906.
Ref. 758. Hinshaw TP, et al. (2024) J Surg Res, 295: 763.
Ref. 759. Mata DA, et al. (2023) N Engl J Med, 388: 281.
Ref. 760. Awasthi S, et al. (2022) J Natl Cancer Inst, 114: 1656.
Ref. 761. Kwon DH, et al. (2023) JCO Oncol Pract, 19: e773.
Ref. 762. Frey MK, et al. (2022) Am Soc Clin Oncol Educ Book, 42: 1.
Ref. 763. Marin-Acevedo JA, et al. (2021) J Hematol Oncol, 14: 45.
Ref. 764. Garon EB, et al. (2019) J Clin Oncol, 37: 2518.
Ref. 765. Lee M, et al. (2023) J Natl Compr Canc Netw, 21: 1269.
Ref. 766. Chang A, et al. (2023) J Natl Cancer Inst, 115: 1224.
Ref. 767. Gupta A, et al. (2022) J Immunother, 45: 132.
Ref. 768. Gupta A, et al. (2023) Sci Rep, 13: 8190.
Ref. 769. Li M, et al. (2023) J Manag Care Spec Pharm, 29: 1232.
Ref. 770. Ramkumar SP, et al. (2023) JAMA Otolaryngol Head Neck Surg, 149: 912.
Ref. 771. US Food and Drug Administration. Expanded Access. Information for Physicians. Accessed: March 30, 2024. Available from:
https://www.fda.gov/news-events/expanded-access/expanded-access-information-physicians
Ref. 772. Ermer T, et al. (2022) JAMA Netw Open, 5: e2219535.
Ref. 773. Carroll CE, et al. (2023) JAMA Oncol, 9: 324.
Ref. 774. Brawley OW, et al. (2021) JCO Glob Oncol, 7: 1537.
Ref. 775. Nassar AH, et al. (2022) Cancer Cell, 40: 1161.
Ref. 776. Ashrafzadeh S, et al. (2021) JAMA Oncol, 7: 1115.
Ref. 777. Newman H, et al. (2023) Blood, 141: 609.
Ref. 778. Kittai AS, et al. (2024) Am J Hematol, 99: 780.
Ref. 779. Wu SP, et al. (2023) JAMA Netw Open, 6: e2349026.
Ref. 780. Sayegh N, et al. (2023) JAMA Netw Open, 6: e2326546.
Ref. 781. Khalaf N, et al. (2024) Pancreas, 53: e27.
Ref. 782. Heiden BT, et al. (2022) Chest, 162: 920.
Ref. 783. Olateju OA, et al. (2022) Front Oncol, 12: 1092355.
Ref. 784. Peng SH, et al. (2023) Cancer Med, 12: 20035.
Ref. 785. Tamirisa N, et al. (2023) Ann Surg, DOI: 10.1097/SLA.0000000000006177.
Ref. 786. Chavez-MacGregor M, et al. (2023) J Natl Cancer Inst, 115: 644.
Ref. 787. Hoehn RS, et al. (2021) Ann Surg Oncol, 28: 2438.
Ref. 788. Hoehn RS, et al. (2024) Ann Surg Oncol, 31: 1906.
Ref. 789. Kelly KN, et al. (2021) Breast Cancer Res Treat, 187: 197.
Ref. 790. Mootz AR, et al. (2024) Acad Radiol: S1076.
Ref. 791. Dixit N et al, (2021) Am Soc Clin Oncol Educ Book, 41: 3.
Ref. 792. Editorial (2021) The Lancet Oncology, 22: 1643.
Ref. 793. National Cancer Institute. Black patients are more likely to die of cancer -here’s how one group is tackling that. Accessed: April 22, 2022. Available from:
https://www.cancer.gov/news-events/cancer-currents-blog/2021/black-white-cancer-disparities-survival-accure
Ref. 794. Griesemer I, et al. (2023) Health Promot Pract, 24: 415.
Ref. 795. Charlot M, et al. (2022) J Clin Oncol, 40: 1755.
Ref. 796. Griesemer I, et al. (2023) SSM Qual Res Health, 3: 100204.
Ref. 797. Graboyes EM, et al. (2023) J Natl Compr Canc Netw, 21: 1251.
Ref. 798. Allen AJ, et al. (2023) Int J Radiat Oncol Biol Phys, 117: S15.
Ref. 799. Gorin SS, et al. (2017) Ann Behav Med, 51: 532.
Ref. 800. Patel VR, et al. (2023) JAMA Oncol, 9: 1001.
References 801-850
Ref. 801. Scott LC, et al. (2021) MMWR Morb Mortal Wkly Rep, 70: 1.
Ref. 802. Nielsen S, et al. (2023) Urol Oncol, 41: 429 e15.
Ref. 803. Raisi-Estabragh Z, et al. (2023) Int J Cardiol Cardiovasc Risk Prev, 19: 200218.
Ref. 804. Mandelblatt JS, et al. (2023) Cancer, 129: 1557.
Ref. 805. Berkman AM, et al. (2024) Cancer, 130: 553.
Ref. 806. Zhang X, et al. (2022) JAMA Netw Open, 5: e221671.
Ref. 807. Hayes SC, et al. (2008) J Clin Oncol, 26: 3536.
Ref. 808. Armer JM, et al. (2019) JAMA Surg, 154: 800.
Ref. 809. Montagna G, et al. (2022) JAMA Oncol, 8: 1195.
Ref. 810. Ren Y, et al. (2022) Cancer, 128: 4119.
Ref. 811. Rock CL, et al. (2022) CA Cancer J Clin, 72: 230.
Ref. 812. Donahue PMC, et al. (2023) Breast Cancer Res Treat, 200: 1.
Ref. 813. Yedjou CG, et al. (2019) Adv Exp Med Biol, 1152: 31.
Ref. 814. Leung TH, et al. (2023) Cancer Med, 12: 22316.
Ref. 815. Sreeram K, et al. (2023) Cancer Causes Control, 34: 459.
Ref. 816. Ames BN, et al. (2021) Nutrients, 13: 499.
Ref. 817. Galsky MD, et al. (2022) J Clin Oncol, 40: TPS4613.
Ref. 818. National Cancer Institute. Cancer in children and adolescents. Accessed: June 30, 2022. Available from:
https://www.cancer.gov/types/childhood-cancers/child-adolescent-cancers-fact-sheet
Ref. 819. Erdmann F, et al. (2021) Cancer Epidemiol, 71: 101733.
Ref. 820. Ghazal LV, et al. (2021) Cancer Nurs, 44: E636.
Ref. 821. Parsons HM, et al. (2014) Cancer, 120: 2352.
Ref. 822. Meernik C, et al. (2021) Cancer, 127: 137.
Ref. 823. Hastert TA, et al. (2022) Cancer Epidemiol Biomarkers Prev, 31: 876. Available from:
https://aacrjournals.org/cebp/article/31/4/876/694021/Financial-Hardship-by-Age-at-Diagnosis-Including
Ref. 824. Kim S, et al. (2023) BMC Med, 21: 289.
Ref. 825. Mobley EM, et al. (2023). Cancer Med, 12:18281.
Ref. 826. Berkman AM, et al. (2023) J Cancer Surviv, 17: 848.
Ref. 827. Geller AC, et al. (2019) J Invest Dermatol, 139: 1898.
Ref. 828. Miller KA, et al. (2023) Cancer Med, 12: 8557.
Ref. 829. Sitlinger A, et al. (2018) Surg Oncol Clin N Am, 27: 675.
Ref. 830. Park J, et al. (2021) Cancer, 127: 1114.
Ref. 831. Eichler M, et al. (2022) Br J Cancer, 126: 1346.
Ref. 832. Reeve BB, et al. (2023) J Natl Cancer Inst, 115: 258.
Ref. 833. Manne S, et al. (2023) BMC Cancer, 23: 664.
Ref. 834. Rincones O, et al. (2021) Cancer Manag Res, 13: 3803.
Ref. 835. Papini C, et al. (2023) Cancer, 129: 1117.
Ref. 836. Chang WH, et al. (2022) Nat Med, 28: 860.
Ref. 837. Camacho-Rivera M, et al. (2022) Health Equity, 6: 729.
Ref. 838. Robien K, et al. (2023) J Acad Nutr Diet, 123: 330.
Ref. 839. Katayama ES, et al. (2024) Ann Surg Oncol, 31: 49.
Ref. 840. Robinson JRM, et al. (2023) J Cancer Surviv, DOI: 10.1007/s11764-023-01471-5.
Ref. 841. Islam JY, et al. (2022) Health Equity, 6: 435.
Ref. 842. Sharareh N, et al. (2024) J Gen Intern Med, 39: 52.
Ref. 843. Reinhart CA, et al. (2020) J Cancer Surviv, 14: 43.
Ref. 844. Bastian TD, et al. (2020) JCO Glob Oncol, 6: 161.
Ref. 845. Burhansstipanov L, et al. (2012) J Cancer Educ, 27: S106.
Ref. 846. Lee YS, et al. (2023) J Evid Based Soc Work (2019), 20: 536.
Ref. 847. Rohan EA, et al. (2022) JCO Oncol Pract, 18: e1704.
Ref. 848. Kronfli D, et al. (2022) Int J Radiat Oncol Biol Phys, 114: 185.
Ref. 849. Samuel CA, et al. (2016) Breast Cancer Res Treat, 160: 1.
Ref. 850. Pinheiro LC, et al. (2015) Cancer, 121: 1312.
References 851-900
Ref. 851. Claridy MD, et al. (2018) Qual Life Res, 27: 2067.
Ref. 852. Matthews AK, et al. (2012) Cancer Nurs, 35: 355.
Ref. 853. Lechner SC, et al. (2012) Couns Psychol, 41: 286.
Ref. 854. Whitehead NE, et al. (2015) Psychooncology, 24: 497.
Ref. 855. Aburizik A, et al. (2023) Psychooncology, 32: 933.
Ref. 856. Samuel CA, et al. (2020) Qual Life Res, 29: 2615.
Ref. 857. Torres-Blasco N, et al. (2023) Palliat Support Care, 21: 461.
Ref. 858. Carrion IV, et al. (2022) Human Soc Sci Comm, 9: 357.
Ref. 859. Guan T, et al. (2023) Front Psychol, 14: 1052229.
Ref. 860. Hoyt MA, et al. (2023) J Psychosoc Oncol, 41: 661.
Ref. 861. Schefter A, et al. (2022) Cancer Rep (Hoboken), 5: e1461.
Ref. 862. Hutchcraft ML, et al. (2021) LGBT Health, 8: 68.
Ref. 863. Hart TL, et al. (2014) J Sex Med, 11: 2308.
Ref. 864. Kamen CS, et al. (2024) Cancer, 130: 1292.
Ref. 865. Franco-Rocha OY, et al. (2023) Psychooncology, 32: 834.
Ref. 866. Yabroff KR, et al. (2022) J Natl Cancer Inst, 114: 863.
Ref. 867. Tak HJ, et al. (2023) J Natl Cancer Inst, 115: 239.
Ref. 868. Centers for Disease Control and Prevention. High-deductible Health Plan Enrollment Among Adults Aged 18–64 With Employment-based Insurance Coverage. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/nchs/products/databriefs/db317.htm
Ref. 869. Zafar SY (2016) J Natl Cancer Inst, 108: djv370.
Ref. 870. Brown JC, et al. (2023) Br J Sports Med, 57: 965.
Ref. 871. Gonzalo-Encabo P, et al. (2023) Curr Oncol Rep, 25: 1237.
Ref. 872. Bea JW, et al. (2023) Exerc Sport Mov, 1: e00007.
Ref. 873. Goerge A, et al. (2023) J Racial Ethn Health Disp. DOI: 10.1007/s40615-023-01791-3
Ref. 874. Hardcastle SJ, et al. (2024) J Sport Health Sci, 13: 81.
Ref. 875. Ng AP, et al. (2022) Gynecol Oncol, 166: 200.
Ref. 876. Noel CW, et al. (2023) JAMA Otolaryngol Head Neck Surg, 149: 63.
Ref. 877. White V, et al. (2023) Med J Aust, 219: 28.
Ref. 878. Karim MA, et al. (2022) Cancer Res Commun, 2: 1119.
Ref. 879. Andreu Y, et al. (2023) Health Qual Life Outcomes, 21: 44.
Ref. 880. Grabowski DC, et al. (2023) Jama Network Open, 6: e2315823.
Ref. 881. Ragavan MV, et al. (2024) JCO Oncol Pract, 20: 291.
Ref. 882. Giles C, et al. (2019) BMJ, 366: l5120.
Ref. 883. Molenaar CJL, et al. (2023) JAMA Surg, 158: 572.
Ref. 884. Loewen I, et al. (2021) J Otolaryngol Head Neck Surg, 50: 2.
Ref. 885. Conderino SE, et al. (2021) Am J Prev Med, 61: 394.
Ref. 886. Stevens CJ, et al. (2023) J Natl Cancer Inst Monogr, 2023: 125.
Ref. 887. Radbruch L, et al. (2020) J Pain Symptom Manage, 60: 754.
Ref. 888. Jackson I, et al. (2024) Cancer Cause Control, 35: 711.
Ref. 889. Elk R, et al. (2018) Semin Oncol Nurs, 34: 303.
Ref. 890. Khullar K, et al. (2022) BMJ Support Palliat Care. Available from:
https://doi.org/10.1136/spcare-2022-004038
Ref. 891. van Klinken M, et al. (2023) Semin Oncol Nurs, 39: 151500.
Ref. 892. Haviland K, et al. (2021) Health Soc Care Community, 29: 305.
Ref. 893. Bakitas MA, et al. (2015) Cancer Control, 22: 450.
Ref. 894. Charlton M, et al. (2015) Oncology (Williston Park), 29: 633.
Ref. 895. Berkman C, et al. (2024) Palliat Support Care, 22: 3.
Ref. 896. Liska TM, et al. (2020) Health Qual Life Outcomes, 18: 197.
Ref. 897. Shani P, et al. (2022) Integr Cancer Ther, 21: 15347354221103275.
Ref. 898. Smith SK, et al. (2018) Am Soc Clin Oncol Educ Book, 38: 813.
Ref. 899. Flores NJ, et al. (2021) Cureus, 13: e14158.
Ref. 900. Menger F, et al. (2021) Support Care Cancer, 29: 7013.
References 901-950
Ref. 901. Moye J, et al. (2020) J Health Psychol, 25: 1222.
Ref. 902. Steinberg DM, et al. (2020) J Adolesc Young Adult Oncol, 9: 239.
Ref. 903. Sumalla EC, et al. (2009) Clin Psychol Rev, 29: 24.
Ref. 904. National Partnership for Women and Families. Paid Leave Could Keep More Than 6 Million Caregivers Connected to the Labor Force by 2030. Accessed: March 26, 2024. Available from:
https://nationalpartnership.org/wp-content/uploads/2023/02/paid-leave-caregivers-connected-2030.pdf
Ref. 905. Lee LJ, et al. (2022) Stress, 25: 258.
Ref. 906. Fenton A, et al. (2022) Support Care Cancer, 30: 9625.
Ref. 907. Hastert TA, et al. (2024) J Cancer Surviv, 18: 565.
Ref. 908. Evans EM, et al. (2023) Pediatr Blood Cancer: e30496.
Ref. 909. Patel MI, et al. (2024) J Clin Oncol, 42: 518.
Ref. 910. The White House. FACT SHEET: Biden Cancer Moonshot Announces Commitments from Leading Health Insurers and Oncology Providers to Make Navigation Services Accessible to More than 150 Million Americans. Accessed April 24, 2024. Available from:
https://www.whitehouse.gov/ostp/news-updates/2024/03/08/fact-sheet-biden-cancer-moonshot-announces-commitments-from-leading-health-insurers-and-oncology-providers-to-make-navigation-services-accessible-to-more-than-150-million-americans/
Ref. 911. Rohan, E, et al. (2022) J Rural Health, 38: 4.
Ref. 912. Lewis-Thames M, et al. (2023) Innov Aging, 7: 228.
Ref. 913. Morris BB, et al. (2022) J Rural Health, 38: 493.
Ref. 914. Thota R, et al. (2020) JCO Oncol Pract, 16: e557.
Ref. 915. Lee MJ, et al. (2023) J Clin Oncol, 41: e13686.
Ref. 916. Percac-Lima S, et al. (2016) JAMA Intern Med, 176: 930.
Ref. 917. Ritvo PG, et al. (2015) Cancer Epidemiol Biomarkers Prev, 24: 506. Available from:
https://aacrjournals.org/cebp/article/24/3/506/115339/Personal-Navigation-Increases-Colorectal-Cancer
Ref. 918. Percac-Lima S, et al. (2015) Cancer, 121: 1662.
Ref. 919. Liang H, et al. (2020) Health Care Manage Rev, 45: 364.
Ref. 920. Edward JS, et al. (2023) JCO Oncol Pract, 19: e696.
Ref. 921. Walls M, et al. (2021) Front Public Health, 9: 788285.
Ref. 922. Smith GL, et al. (2022) CA Cancer J Clin, 72: 437.
Ref. 923. Winkfield KM, et al. (2017) Am Soc Clin Oncol Educ Book, 37: 18.
Ref. 924. Center to Reduce Cancer Health Disparities. The CURE Paradigm: Enhancing Workforce Diversity. Accessed: March 27, 2024. Available from:
https://www.cancer.gov/about-nci/organization/crchd/crchd-cure-paradigm.pdf
Ref. 925. Thomas AG, et al. (2023) Oncologist, 28: e1131.
Ref. 926. Liblik K, et al. (2022) Res Pract Thromb Haemost, 6: e12767.
Ref. 927. Tsugawa Y, et al. (2017) JAMA Intern Med, 177: 206.
Ref. 928. Mast MS, et al. (2018) Patient Educ Couns, 101: 1697.
Ref. 929. National Center for Education Statistics. Science, Technology, Engineering, and Mathematics (STEM) Education, by Gender. Accessed: March 26, 2024. Available from:
https://nces.ed.gov/fastfacts/display.asp?id=899
Ref. 930. National Center for Science and Engineering Statistics. Diversity and STEM: Women, Minorities, and Persons with Disabilities 2023. Special Report NSF 23-315. Accessed: March 26, 2024. Available from:
https://ncses.nsf.gov/pubs/nsf23315
Ref. 931. Callis-Duehl K, et al. (2023) J STEM Outreach, 6: 1.
Ref. 932. Pew Research Center. Blacks in STEM jobs are especially concerned about diversity and discrimination in the workplace. Accessed: March 17, 2024. Available from:
https://www.pewresearch.org/social-trends/2018/01/09/blacks-in-stem-jobs-are-especially-concerned-about-diversity-and-discrimination-in-the-workplace/
Ref. 933. National Academies of Sciences, Engineering, and Medicine. 2019. The Science of Effective Mentorship in STEMM. Washington, DC: The National Academies Press. Available from: https://doi.org/10.17226/25568.
Ref. 934. National Cancer Institute. Continuing Umbrella of Research Experience (CURE). Accessed: July 5, 2023. Available from:
https://www.cancer.gov/about-nci/organization/crchd/diversity-training/cure/cure-infographic.pdf
Ref. 935. US National Science Foundation. Broadening Participation in STEM. Accessed: March 17, 2024. Available from:
https://new.nsf.gov/funding/initiatives/broadening-participation
Ref. 936. Congress.gov. Chips and Science Act. Accessed: March 26, 2024. Available from:
https://www.congress.gov/bill/117th-congress/house-bill/4346/text
Ref. 937. US National Science Foundation. NSF’s Eddie Bernice Johnson Inclusion Across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science Initiative. Accessed: March 17, 2024. Available from:
https://new.nsf.gov/funding/opportunities/nsfs-eddie-bernice-johnson-inclusion-across-nation
Ref. 938. The White House. FACT SHEET: CHIPS and Science Act Will Lower Costs, Create Jobs, Strengthen Supply Chains, and Counter China | The White House. Accessed: March 30, 2024. Available from:
https://www.whitehouse.gov/briefing-room/statements-releases/2022/08/09/fact-sheet-chips-and-science-act-will-lower-costs-create-jobs-strengthen-supply-chains-and-counter-china/
Ref. 939. United Negro College Fund. Accessed: March 17, 2024. Available from:
https://uncf.org/
Ref. 940. National Science Foundation. Historically Black Colleges and Universities -Excellence in Research (HBCU -EiR). Accessed: March 26, 2024. Available from:
https://new.nsf.gov/funding/opportunities/historically-black-colleges-universities-0
Ref. 941. National Science Foundation. Tribal Colleges and Universities Program (TCUP). Accessed: March 26, 2024. Available from:
https://new.nsf.gov/funding/opportunities/tribal-colleges-universities-program-tcup
Ref. 942. National Science Foundation. Improving Undergraduate STEM Education: Hispanic-Serving Institutions (HSI Program). Accessed: March 26, 2024. Available from:
https://new.nsf.gov/funding/opportunities/improving-undergraduate-stem-education-hispanic
Ref. 943. National Action Council for Minorities in Engineering. About NACME. Accessed: March 26, 2024. Available from:
https://www.nacme.org/about-us
Ref. 944. US Department of Education. Asian American and Native American Pacific Islander-Serving Institutions Program. Accessed: March 26, 2024. Available from:
https://www2.ed.gov/programs/aanapi/index.html
Ref. 945. Parsons JRM, et al. (2021) J STEM Outreach, 4.
Ref. 946. Alfred L, et al. (2011) J Cancer Educ, 26: 223.
Ref. 947. Hein DW, et al. (2018) J Cancer Educ, 33: 298.
Ref. 948. Qua K, et al. (2020) Ethn Dis, 30: 15.
Ref. 949. The White House. Equity and Excellence: A Vision to Transform and Enhance the U.S. STEMM Ecosystem. Accessed: March 17, 2024. Available from:
https://www.whitehouse.gov/ostp/news-updates/2022/12/12/equity-and-excellence-a-vision-to-transform-and-enhance-the-u-s-stemm-ecosystem/
Ref. 950. Boulware LE, et al. (2022) N Engl J Med, 386: 201.
References 951-1000
Ref. 951. Office of Planning, Evaluation and Policy Development. US Department of Education. Advancing Diversity and Inclusion in Higher Education. Accessed: March 17, 2024. Available from:
https://www2.ed.gov/rschstat/research/pubs/advancing-diversity-inclusion.pdf
Ref. 952. The Advisory Committee to the Director Working Group on Diversity. Racism in Science Report. Accessed: March 17, 2024. Available from:
https://acd.od.nih.gov/documents/presentations/02262021DiversityReport.pdf
Ref. 953. Taffe MA, et al. (2021) eLife, 10: 1.
Ref. 954. Cadena MA, et al. (2023) Cell, 186: 3529.
Ref. 955. Faiz J, et al. (2023) JAMA Health Forum, 4: e230498.
Ref. 956. Association of American Medical Colleges. AAMC Data & Reports. Accessed: March 27, 2024. Available from:
https://www.aamc.org/data-reports
Ref. 957. Association of American Medical Colleges. Unconscious Bias in Faculty and Leadership Recruitment: A Literature Review. Accessed: March 17, 2024. Available from:
https://www.aamc.org/media/5826/download
Ref. 958. Mass General Research Institute. Study Finds More Efforts Are Needed to Increase Diversity Among Cancer Clinicians. Accessed: March 17, 2024. Available from:
https://mgriblog.org/2022/02/02/study-finds-more-efforts-are-needed-to-increase-diversity-among-cancer-clinicians/
Ref. 959. Sottile E, et al. (2023) J Gen Intern Med: s11606.
Ref. 960. Ly DP, et al. (2022) Ann Intern Med, 175: 873.
Ref. 961. Pereira RI, et al. (2024) Lancet, 403: 332.
Ref. 962. Kamran SC, et al. (2022) JAMA Oncol, 8: 221.
Ref. 963. Science. NIH advisory group recommends $14,000 boost in postdoc pay. Accessed: March 17, 2024. Available from:
https://www.science.org/content/article/nih-advisory-group-recommends-14-000-boost-postdoc-pay
Ref. 964. National Institutes of Health. Ending Structural Racism. UNITE. Accessed: March 17, 2024. Available from:
https://www.nih.gov/ending-structural-racism/unite
Ref. 965. The National Institutes of Health. The UNITE Progress Report 2021-2022. Accessed: March 17, 2024. Available from:
https://www.nih.gov/sites/default/files/research-training/initiatives/ending-structural-racism/UNITE-progress-report-2022.pdf
Ref. 966. Lerman C, et al. (2022) J Natl Cancer Inst, 114: 1214.
Ref. 967. Association of American Medical Colleges. Report on Residents. Accessed: March 17, 2024. Available from:
https://www.aamc.org/data-reports/students-residents/report/report-residents
Ref. 968. Association of American Medical Colleges. Physician Specialty Data Report. Accessed: March 17, 2024. Available from:
https://www.aamc.org/data-reports/workforce/report/physician-specialty-data-report
Ref. 969. Snyder JE, et al. (2023) JAMA Netw Open, 6: e236687.
Ref. 970. Daley GQ, et al. (2021) Med, 2: 2.
Ref. 971. Winkfield KM, et al. (2021) JCO Oncol Pract, 17: 224.
Ref. 972. Shuler HD, et al. (2022) Cell, 185: 2841.
Ref. 973. ASCO (2022) JCO Oncol Pract, 18: 396.
Ref. 974. Duma N, et al. (2022) JCO Oncol Pract, 18: 388.
Ref. 975. Xierali IM, et al. (2018) J Health Care Poor Underserved, 29: 556.
Ref. 976. Balderas-Medina Anaya Y, et al. (2022) Acad Med, 97: 398.
Ref. 977. Lopez CL, et al. (2021) JAMA Netw Open, 4: e219219.
Ref. 978. Husmann DA, et al. (2021) Urol Pract, 8: 583.
Ref. 979. Congressional Research Service. Medicare Graduate Medical Education Payments: An Overview. Accessed: March 17, 2024. Available from:
https://crsreports.congress.gov/product/pdf/IF/IF10960
Ref. 980. American Medical Association. 2023 Compendium of Graduate Medical Education Initiatives Report. Accessed: March 17, 2024. Available from:
https://www.ama-assn.org/system/files/2023-gme-compendium-report.pdf
Ref. 981. Salsberg E, et al. (2008) JAMA, 300: 1174.
Ref. 982. Rains J, et al. (2023) JAMA, 330: 968.
Ref. 983. Kwan MMS, et al. (2017) PLoS One, 12: e0180394.
Ref. 984. Playford D, et al. (2017) Aust J Rural Health, 25: 210.
Ref. 985. McGrail MR, et al. (2018) Hum Resour Health, 16: 56.
Ref. 986. Goodfellow A, et al. (2016) Acad Med, 91: 1313.
Ref. 987. Fagan EB, et al. (2013) Am Fam Physician, 88: 704.
Ref. 988. Dyrbye LN, et al. (2023) JAMA, 330: 1797.
Ref. 989. Schleiter K, et al. (2021) J Grad Med Educ, 13: 602.
Ref. 990. National Institutes of Health. Physician-Scientist Workforce Working Group Report. Accessed: March 17, 2024. Available from:
https://acd.od.nih.gov/documents/reports/PSW_Report_ACD_06042014.pdf
Ref. 991. Bannerman C, et al. (2020) Mol Biol Cell, 31: 2640.
Ref. 992. Ayedun A, et al. (2023) JAMA Netw Open, 6: e2310795.
Ref. 993. Siebert AL, et al. (2020) BMC Med Educ, 20: 422.
Ref. 994. Nguyen M, et al. (2023) JAMA Intern Med, 183: 1021.
Ref. 995. In: Vargas EA, Scherer LA, Fiske ST, Barabino GA, editors. Advancing Antiracism, Diversity, Equity, and Inclusion in STEMM Organizations: Beyond Broadening Participation. Washington (DC) 2023.
Ref. 996. Krecko LK, et al. (2022) Health Equity, 6: 873.
Ref. 997. The Chronicle. Opinion: Two Big Things Colleges Can Do Right Now to Increase Diversity. Accessed: March 17, 2024. Available from:
https://www.chronicle.com/article/expanding-access-after-affirmative-action
Ref. 998. Smiley RA, et al. (2023) J Nurs Regul, 14: S1.
Ref. 999. Hassmiller SB, et al. (2022) Nurs Outlook, 70: S1.
Ref. 1000. Bradley-Guidry C, et al. (2022) BMC Med Educ, 22: 680.
References 1001-1050
Ref. 1001. Congress.gov. Text – H.R.2274 – 117th Congress (2021-2022): Physician Assistant Higher Education Modernization Act of 2021. Accessed: March 17, 2024. Available from:
https://www.congress.gov/bill/117th-congress/house-bill/2274/text
Ref. 1002. Harris JA, et al. (2022) Front Oral Health, 3: 874332.
Ref. 1003. American Dental Association. U.S. Dentist Demographics. Accessed: March 17, 2024. Available from: https://www.ada.org/resources/research/health-policy-institute/us-dentist-demographics
Ref. 1004. Shillingburg A, et al. (2020) J Oncol Pharm Pract, 26: 175.
Ref. 1005. George A, et al. (2023) HCA Healthc J Med, 4: 77.
Ref. 1006. Holle LM, et al. (2020) Pharmacy (Basel), 8: 130.
Ref. 1007. NIH Common Fund. Transformative Research to Address Health Disparities and Advance Health Equity. Accessed: March 17, 2024. Available from:
https://commonfund.nih.gov/healthdisparitiestransformation
Ref. 1008. National Institutes of Health. Office of Strategic Coordination-The Common Fund. Community Partnerships to Advance Science for Society (ComPASS). Accessed: March 26, 2024. Available from:
https://commonfund.nih.gov/compass
Ref. 1009. National Institute of Minority Health and Health Disparities. Research Interest Areas. Accessed: March 17, 2024. Available from:
https://www.nimhd.nih.gov/programs/extramural/research-areas/
Ref. 1010. National Cancer Institute. NCI awards $50 million for new Persistent Poverty Initiative. Accessed: March 17, 2024. Available from:
https://www.cancer.gov/news-events/press-releases/2023/nci-launches-persistent-poverty-initiative
Ref. 1011. National Cancer Institute. NCI Center to Reduce Cancer Health Disparities. Accessed: March 17, 2024. Available from:
https://www.cancer.gov/about-nci/organization/crchd
Ref. 1012. National Human Genome Research Institute. Diversity in Genomic Research. Accessed: March 17, 2024. Available from:
https://www.genome.gov/about-genomics/fact-sheets/Diversity-in-Genomic-Research
Ref. 1013. Centers for Disease Control and Prevention. What CDC Is Doing to Achieve Equity in Cancer Control. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/cancer/health-equity/what-cdc-is-doing/index.htm
Ref. 1014. Centers for Disease Control and Prevention. CDC’s CORE Commitment to Health Equity. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/healthequity/core/
Ref. 1015. Centers for Disease Control and Prevention. Reducing Cancer Disparities Through Partnerships. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/cancer/health-equity/what-cdc-is-doing/partnerships.htm
Ref. 1016. Nardone A, et al. (2021) Environ Health Perspect, 129: 17006.
Ref. 1017. Public Health Law Center. The Tobacco Industry & the Black Community: The Targeting of African Americans. Accessed: March 17, 2024. Available from:
https://www.publichealthlawcenter.org/resources/tobacco-industry-black-community-targeting-african-americans
Ref. 1018. Villanti AC, et al. (2017) BMC Public Health, 17: 1.
Ref. 1019. Ross KC, et al. (2016) Cancer Epidemiol Biomarkers Prev, 25: 936. Available from:
https://aacrjournals.org/cebp/article/25/6/936/282907/The-Influence-of-Puff-Characteristics-Nicotine
Ref. 1020. Okuyemi KS, et al. (2007) Addiction, 102: 1979.
Ref. 1021. Los Angeles Times. FDA moves toward restricting menthol in cigarettes. Accessed: March 27, 2024. Available from:
https://www.latimes.com/science/la-xpm-2013-jul-23-la-sci-menthol-cigarettes-20130724-story.html
Ref. 1022. Tobacco Control Legal Consortium et al. Citizen Petition to Food & Drug Admin., Prohibiting Menthol as a Characterizing Flavor in Cigarettes (Apr. 12, 2013). Accessed: March 28, 2024. Available from:
https://www.aacr.org/wp-content/uploads/2019/11/tclc-fdacitizenpetition-menthol-2013 F3F578.pdf
Ref. 1023. Food and Drug Administration. Tobacco Product Standard for Menthol in Cigarettes. Accessed: March 17, 2024. Available from:
https://public-inspection.federalregister.gov/2022-08994.pdf
Ref. 1024. Cadham CJ, et al. (2020) BMC Public Health, 20: 1055.
Ref. 1025. Levy DT, et al. (2023) Tob Control, 32: e37.
Ref. 1026. Public Health Law Center. Proposition 31 in California Passed! Now What? Accessed: March 17, 2024. Available from:
https://www.publichealthlawcenter.org/commentary/221109/11/9/22-proposition-31-california-passed-now-what
Ref. 1027. The New York Times. R.J. Reynolds Pivots to New Cigarette Pitches as Flavor Ban Takes Effect. Accessed: March 17, 2024. Available from:
https://www.nytimes.com/2023/01/11/health/cigarettes-flavor-ban-california.html
Ref. 1028. Nyman AL, et al. (2016) Tob Regul Sci, 2: 239.
Ref. 1029. Ambrose BK, et al. (2015) JAMA, 314: 1871.
Ref. 1030. Kong G, et al. (2017) Tob Regul Sci, 3: S48.
Ref. 1031. Federal Register. Tobacco Product Standard for Characterizing Flavors in Cigars. Accessed: March 17, 2024. Available from:
https://www.federalregister.gov/documents/2022/05/04/2022-08993/tobacco-product-standard-for-characterizing-flavors-in-cigars
Ref. 1032. Rostron BL, et al. (2019) Int J Environ Res Public Health, 16: 3234.
Ref. 1033. Richard P, et al. (2012) PLoS One, 7: e29665.
Ref. 1034. Ramsey AT, et al. (2019) BMJ Open, 9: e030066.
Ref. 1035. smokefree.gov. Smokefree. Accessed: March 17, 2024. Available from:
https://smokefree.gov/
Ref. 1036. Centers for Disease Control and Prevention. Tips From Former Smokers. Accessed: March 17, 2024. Available from:
https://www.cdc.gov/tobacco/campaign/tips/index.html
Ref. 1037. Stanford Medicine. How menthol cigarette ads target Black people, women and teens. Accessed: March 26, 2024. Available from:
https://scopeblog.stanford.edu/2022/10/18/how-menthol-cigarette-ads-target-black-people-women-and-teens/
Ref. 1038. US Environmental Protection Agency. Environmental Justice. Accessed: March 17, 2024. Available from:
https://www.epa.gov/environmentaljustice
Ref. 1039. US Environmental Protection Agency. EPA Efforts to Reduce Exposure to Carcinogens and Prevent Cancer. Accessed: March 17, 2024. Available from:
https://www.epa.gov/environmental-topics/epa-efforts-reduce-exposure-carcinogens-and-prevent-cancer
Ref. 1040. US Environmental Protection Agency. The National Radon Action Plan -A Strategy for Saving Lives. Accessed: March 17, 2024. Available from:
https://www.epa.gov/radon/national-radon-action-plan-strategy-saving-lives
Ref. 1041. National Radon Action Plan. Reflections on the National Radon Action Plan’s (NRAP) Progress, 2015–2020. Accessed: March 17, 2024. Available from:
http://www.radonleaders.org/sites/default/files/2021-11/NRAP_Accomplishments_2015-2020_Alt-CVR_508.pdf
Ref. 1042. National Radon Action Plan. The National Radon Action Plan 2021–2025 Eliminating Preventable Lung Cancer From Radon in the United States by Expanding Protections for All Communities and Buildings. Accessed: March 17, 2024. Available from:
http://www.radonleaders.org/sites/default/files/2022-01/NRAP-2021-2025-Action-Plan-508.pdf
Ref. 1043. US Environmental Protection Agency. Summary of the Toxic Substances Control Act. Accessed: March 17, 2024. Available from:
https://www.epa.gov/laws-regulations/summary-toxic-substances-control-act
Ref. 1044. US Environmental Protection Agency. Biden-Harris Administration Proposes Ban on Trichloroethylene to Protect Public from Toxic Chemical Known to Cause Serious Health Risks. Accessed: March 17, 2024. Available from:
https://www.epa.gov/newsreleases/biden-harris-administration-proposes-ban-trichloroethylene-protect-public-toxic
Ref. 1045. US Environmental Protection Agency. EPA Proposes Ban on All Consumer, Most Industrial and Commercial Uses of Methylene Chloride to Protect Public Health. Accessed: March 17, 2024. Available from:
https://www.epa.gov/newsreleases/epa-proposes-ban-all-consumer-most-industrial-and-commercial-uses-methylene-chloride
Ref. 1046. US Environmental Protection Agency. Proposed Designation of Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS) as CERCLA Hazardous Substances. Accessed: March 17, 2024. Available from:
https://www.epa.gov/superfund/proposed-designation-perfluorooctanoic-acid-pfoa-and-perfluorooctanesulfonic-acid-pfos
Ref. 1047. US Environmental Protection Agency. Per-and Polyfluoroalkyl Substances (PFAS). Accessed: March 17, 2024. Available from:
https://www.epa.gov/sdwa/and-polyfluoroalkyl-substances-pfas
Ref. 1048. US Environmental Protection Agency. EJScreen: Environmental Justice Screening and Mapping Tool. Accessed: March 17, 2024. Available from:
https://www.epa.gov/ejscreen
Ref. 1049. US Environmental Protection Agency. Environmental Justice Grants, Funding and Technical Assistance. Accessed: March 17, 2024. Available from:
https://www.epa.gov/environmentaljustice/environmental-justice-grants-funding-and-technical-assistance
Ref. 1050. Fiscella K, et al. (2011) J Health Care Poor Underserved, 22: 83.
References 1051-1108
Ref. 1051. Brian Dooley. Screening vs. Diagnostic Colonoscopy: What’s The Difference? -Gastroenterologist San Antonio. Accessed: March 17, 2024. Available from:
https://www.gastroconsa.com/screening-vs-diagnostic-colonoscopy-whats-the-difference/
Ref. 1052. Congress.gov. H.R.3382 -118th Congress (2023-2024): Colorectal Cancer Payment Fairness Act. Accessed: March 17, 2024. Available from:
https://www.congress.gov/bill/118th-congress/house-bill/3382
Ref. 1053. National Cancer Institute. Federal Health Legislation. Accessed: March 17, 2024. Available from:
https://www.cancer.gov/about-nci/legislative/current-congress/federal-health
Ref. 1054. Pfizer. Understanding Healthcare Disparities in Colorectal Cancer. Accessed: March 17, 2024. Available from:
https://www.pfizer.com/news/articles/understanding_healthcare_disparities_in_colorectal_cancer
Ref. 1055. Ashley Nellis, Ph.D. The Color of Justice: Racial and Ethnic Disparity in State Prisons. Accessed: March 17, 2024. Available from:
https://www.sentencingproject.org/reports/the-color-of-justice-racial-and-ethnic-disparity-in-state-prisons-the-sentencing-project/
Ref. 1056. Ramaswamy M, et al. (2023) J Natl Cancer Inst, 115: 1128.
Ref. 1057. Salyer C, et al. (2022) J Womens Health (Larchmt), 31: 533.
Ref. 1058. Dolan K, et al. (2016) Lancet, 388: 1089.
Ref. 1059. Joseph AK, et al. (2022) Pediatr Dermatol, 39: 182.
Ref. 1060. Mittendorf KF, et al. (2021) JCO Precis Oncol, 5.
Ref. 1061. NCI Division of Cancer Control and Population Sciences. Prevention and Early Detection for Hereditary Cancer Syndromes. Accessed: March 17, 2024. Available from:
https://cancercontrol.cancer.gov/research-emphasis/contribution-to-the-cancer-moonshot/prevention-and-early-detection
Ref. 1062. Cheng S, et al. (2012) N Biotechnol, 29: 682.
Ref. 1063. Knapp ST, et al. (2023) Cancers (Basel), 15: 391.
Ref. 1064. Bottern J, et al. (2023) Clin Transl Sci, 16: 937.
Ref. 1065. US Food and Drug Administration. Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products Guidance for Industry. Accessed: March 17, 2024. Available from:
https://www.fda.gov/media/175746/download
Ref. 1066. Russell ES, et al. (2023) J Clin Transl Sci, 7: e101.
Ref. 1067. Birhiray MN, et al. (2023) Blood Adv, 7: 1507.
Ref. 1068. Peters U, et al. (2023) Ther Innov Regul Sci, 57: 186.
Ref. 1069. Congress.gov. Text -S.1701 -118th Congress (2023-2024): NIH Clinical Trial Diversity Act of 2023. Accessed: March 17, 2024. Available from:
https://www.congress.gov/bill/118th-congress/senate-bill/1701/text
Ref. 1070. Keegan G, et al. (2023) Surg Oncol Clin N Am, 32: 221.
Ref. 1071. Parast L, et al. (2022) J Gen Intern Med, 37: 49.
Ref. 1072. Brown LE, et al. (2012) West J Emerg Med, 13: 410.
Ref. 1073. US Food and Drug Administration. Project Community. Accessed: March 17, 2024. Available from:
https://www.fda.gov/about-fda/oncology-center-excellence/project-community
Ref. 1074. The White House. A Proclamation on National Native American Heritage Month, 2022. Accessed: March 17, 2024. Available from:
https://www.whitehouse.gov/briefing-room/presidential-actions/2022/10/31/a-proclamation-on-national-native-american-heritage-month-2022/
Ref. 1075. Hotca A, et al. (2023) Curr Oncol, 30: 6362.
Ref. 1076. The Commonwealth Fund. State of U.S. Health Insurance in 2022: Biennial Survey. Accessed: March 17, 2024. Available from:
https://www.commonwealthfund.org/publications/issue-briefs/2022/sep/state-us-health-insurance-2022-biennial-survey
Ref. 1077. Falk DS, et al. (2023) Cancer Surviv Res Care, 1.
Ref. 1078. Hanna TP, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ (Clinical research ed). Volume 3712020. p m4087.
Ref. 1079. KFF. 10 Things to Know About the Unwinding of the Medicaid Continuous Enrollment Provision. Accessed: March 17, 2024. Available from:
https://www.kff.org/medicaid/issue-brief/10-things-to-know-about-the-unwinding-of-the-medicaid-continuous-enrollment-provision/
Ref. 1080. KFF. Medicaid Enrollment and Unwinding Tracker -Overview. Accessed: March 17, 2024. Available from:
https://www.kff.org/report-section/medicaid-enrollment-and-unwinding-tracker-overview/
Ref. 1081. The Commonwealth Fund. Almost 3.8 Million People Lost Medicaid Coverage Since End of PHE. Accessed: March 17, 2024. Available from:
https://www.commonwealthfund.org/blog/2023/almost-38-million-people-have-lost-their-medicaid-coverage-end-covid-19-public-health
Ref. 1082. Centers for Medicare and Medicaid Services. Coverage for Half a Million Children and Families Will Be Reinstated Thanks to HHS’ Swift Action. Accessed: March 17, 2024. Available from:
https://www.cms.gov/newsroom/press-releases/coverage-half-million-children-and-families-will-be-reinstated-thanks-hhs-swift-action
Ref. 1083. Centers for Medicare & Medicaid Services. HHS Takes Additional Action to Keep People Covered as States Resume Medicaid, CHIP Renewals. Accessed: March 17, 2024. Available from:
https://www.cms.gov/newsroom/press-releases/hhs-takes-additional-action-keep-people-covered-states-resume-medicaid-chip-renewals
Ref. 1084. Third Way. Revitalizing Safety Net Hospitals: Protecting Low-Income Americans from Losing Access to Care. Accessed: March 17, 2024. Available from:
https://www.thirdway.org/report/revitalizing-safety-net-hospitals-protecting-low-income-americans-from-losing-access-to-care
Ref. 1085. American Hospital Association. Uncompensated Hospital Care Cost Fact Sheet. Accessed: March 17, 2024. Available from:
https://www.aha.org/system/files/2019-01/uncompensated-care-fact-sheet-jan-2019.pdf
Ref. 1086. Sarkar RR, et al. (2020) Cancer, 126: 4584.
Ref. 1087. American Hospital Association. Rural Hospital Closures Threaten Access Solutions to Preserve Care in Local Communities. Accessed: March 17, 2024. Available from:
https://www.aha.org/system/files/media/file/2022/09/rural-hospital-closures-threaten-access-report.pdf
Ref. 1088. American Society for Radiation Oncology. Radiation oncology workforce study indicates potential threat to rural cancer care access. Accessed: March 17, 2024. Available from:
https://www.newswise.com/articles/radiation-oncology-workforce-study-indicates-potential-threat-to-rural-cancer-care-access
Ref. 1089. American Society of Clinical Oncology. Key Trends in Tracking Supply of and Demand for Oncologists. Accessed: March 17, 2024. Available from:
https://society.asco.org/sites/new-www.asco.org/files/content-files/practice-and-guidelines/documents/2020-workforce-information-system.pdf
Ref. 1090. American Medical Association. Recipe for more rural physicians: More exposure in residency training. Accessed: March 17, 2024. Available from:
https://www.ama-assn.org/medical-residents/transition-resident-attending/recipe-more-rural-physicians-more-exposure
Ref. 1091. The Center for American Progress. Immigrant Doctors Can Help Lower Physician Shortages in Rural America. Accessed: March 17, 2024. Available from:
https://www.americanprogress.org/article/immigrant-doctors-can-help-lower-physician-shortages-rural-america/
Ref. 1092. Tulane University School of Public Health and Tropical Medicine. How to Improve Health Care in Rural Areas. Accessed: March 26, 2024. Available from:
https://publichealth.tulane.edu/blog/how-to-improve-health-care-in-rural-areas/
Ref. 1093. Dixit N, et al. (2021) Am Soc Clin Oncol Educ Book, 41: 1.
Ref. 1094. Freeman HP (2012) Cancer Epidemiol Biomarkers Prev, 21: 1614. Available from:
https://aacrjournals.org/cebp/article/21/10/1614/69026/The-Origin-Evolution-and-Principles-of-Patient
Ref. 1095. Pratt-Chapman ML, et al. (2021) Implement Sci Commun, 2: 141.
Ref. 1096. Congress.gov. H. R. 2617 -Consolidated Appropriations Act, 2023. Accessed: March 17, 2024. Available from:
https://www.congress.gov/117/bills/hr2617/BILLS-117hr2617enr.pdf
Ref. 1097. US Department of Human and Health Services. Access to internet and other telehealth resources. Accessed: March 17, 2024. Available from:
https://telehealth.hhs.gov/providers/best-practice-guides/telehealth-for-rural-areas/access-to-internet-and-other-telehealth-resources
Ref. 1098. The ASCO Post. How Telemedicine Can Transform Clinical Research and Practice. Accessed: March 17, 2024. Available from:
https://ascopost.com/issues/december-25-2022/how-telemedicine-can-transform-clinical-research-and-practice/
Ref. 1099. Li Y, et al. (2023) Public Health, 217: 205.
Ref. 1100. Tevaarwerk AJ, et al. (2021) JCO Oncol Pract, 17: e1318.
Ref. 1101. Basch E, et al. (2017) JAMA, 318: 197.
Ref. 1102. American Cancer Society Cancer Action Network. Survivor Views: Telehealth and Clinical Trials. Accessed: March 17, 2024. Available from:
https://www.fightcancer.org/policy-resources/survivor-views-telehealth-and-clinical-trials-0
Ref. 1103. Forbes. Millions Of Americans Are Still Missing Out On Broadband Access And Leaving Money On The Table—Here’s Why. Accessed: March 26, 2024. Available from:
https://www.forbes.com/advisor/personal-finance/millions-lack-broadband-access/
Ref. 1104. The White House. FACT SHEET: Biden-Harris Administration Announces Over $25 Billion in American Rescue Plan Funding to Help Ensure Every American Has Access to High Speed, Affordable Internet. Accessed: March 17, 2024. Available from:
https://www.whitehouse.gov/briefing-room/statements-releases/2022/06/07/fact-sheet-biden-harris-administration-announces-over-25-billion-in-american-rescue-plan-funding-to-help-ensure-every-american-has-access-to-high-speed-affordable-internet/
Ref. 1105. Congress.gov. S.3321 -118th Congress (2023-2024): Lowering Broadband Costs for Consumers Act of 2023. Accessed: March 17, 2024. Available from:
https://www.congress.gov/bill/118th-congress/senate-bill/3321?s=1&r=5
Ref. 1106. Congress.gov. S.341 -118th Congress (2023-2024): Broadband Grant Tax Treatment Act. Accessed: March 17, 2024. Available from:
https://www.congress.gov/bill/118th-congress/senate-bill/341
Ref. 1107. Centers for Medicare & Medicaid Services. Enhancing Oncology Model. Accessed: March 17, 2024. Available from:
https://www.cms.gov/priorities/innovation/innovation-models/enhancing-oncology-model
Ref. 1108. Centers for Medicare and Medicaid Services. CMS Framework for Health Equity 2022–2032. Accessed: March 17, 2024. Available from:
https://www.cms.gov/files/document/cms-framework-health-equity.pdf
